<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell Commun Signal</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Commun. Signal</journal-id>
<journal-title-group>
<journal-title>Cell Communication and Signaling : CCS</journal-title>
</journal-title-group>
<issn pub-type="epub">1478-811X</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30257675</article-id>
<article-id pub-id-type="pmc">6158828</article-id>
<article-id pub-id-type="publisher-id">274</article-id>
<article-id pub-id-type="doi">10.1186/s12964-018-0274-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cold shock proteins: from cellular mechanisms to pathophysiology and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6846-5056</contrib-id>
<name>
<surname>Lindquist</surname>
<given-names>Jonathan A.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mertens</surname>
<given-names>Peter R.</given-names>
</name>
<address>
<phone>+49-391-6713236</phone>
<email>Peter.Mertens@med.ovgu.de</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1018 4307</institution-id><institution-id institution-id-type="GRID">grid.5807.a</institution-id><institution>Clinic for Nephrology and Hypertension, Diabetology and Endocrinology, </institution><institution>Otto-von-Guericke University Magdeburg, </institution></institution-wrap>Leipziger Strasse 44, 39120 Magdeburg, Germany </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>16</volume>
<elocation-id>63</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Cold shock proteins are multifunctional RNA/DNA binding proteins, characterized by the presence of one or more cold shock domains. In humans, the best characterized members of this family are denoted Y-box binding proteins, such as Y-box binding protein-1 (YB-1). Biological activities range from the regulation of transcription, splicing and translation, to the orchestration of exosomal RNA content. Indeed, the secretion of YB-1 from cells via exosomes has opened the door to further potent activities. Evidence links a skewed cold shock protein expression pattern with cancer and inflammatory diseases. In this review the evidence for a causative involvement of cold shock proteins in disease development and progression is summarized. Furthermore, the potential application of cold shock proteins for diagnostics and as targets for therapy is elucidated.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution>Deutsche Forschungsgemeinschaft (DFG)</institution>
</funding-source>
<award-id>ME-1365/7-2</award-id>
<principal-award-recipient>
<name>
<surname>Mertens</surname>
<given-names>Peter R.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Deutsche Forschungsgemeinschaft (DFG)</institution>
</funding-source>
<award-id>ME-1365/9-1</award-id>
<principal-award-recipient>
<name>
<surname>Mertens</surname>
<given-names>Peter R.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Deutsche Forschungsgemeinschaft (DFG)</institution>
</funding-source>
<award-id>SFB 854, project A01</award-id>
<principal-award-recipient>
<name>
<surname>Mertens</surname>
<given-names>Peter R.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Deutsche Forschungsgemeinschaft (DFG)</institution>
</funding-source>
<award-id>LI-1031/4-1</award-id>
<principal-award-recipient>
<name>
<surname>Lindquist</surname>
<given-names>Jonathan A.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par2">Imagine proteins that are conserved in both structure and function, that can be found in almost all organisms from bacteria to humans (except yeast), and have been detected in almost every cellular compartment. Add to this the ability to regulate not only their own expression, but the expression of a number of disease-associated genes, and to orchestrate multiple cellular processes, including proliferation and differentiation. Who are these jack-of-all-trades? Enter our protagonists, the cold shock proteins.</p>
<sec id="Sec2">
<title>Members of the cold shock protein family</title>
<p id="Par37">Cold shock proteins are among the most evolutionarily conserved proteins [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. Their distinguishing characteristic is the presence of one or more cold shock domains (CSD), which possess nucleic acid binding properties (see Fig. <xref ref-type="fig" rid="Fig1">1</xref> and Table <xref ref-type="table" rid="Tab1">1</xref>). This endows these proteins with pleiotropic functions, such as the regulation of transcription, translation, and splicing [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>The human cold shock domain proteins. The five groups of human cold shock proteins are presented. The number of proteins in each group is indicated within the brackets. The cold shock domain (CSD) is presented in blue. Lin28 contains two additional zinc finger domains (grey bars). The numbers below indicate the approximate number of amino acids. Structure predictions were performed using the SMART software [<xref ref-type="bibr" rid="CR215">215</xref>]</p></caption><graphic id="MO1" xlink:href="12964_2018_274_Fig1_HTML"></graphic></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Nomenclature of the human cold shock domain proteins.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Gene synonym</th><th>Protein</th><th>Alternative names</th></tr></thead><tbody><tr><td>
<italic>YBX1</italic>
</td><td>
<italic>MSY1</italic>
</td><td>
<bold>YB-1</bold>
</td><td>CSDB, DbpB, NSEP1, EF1A</td></tr><tr><td>
<italic>YBX2</italic>
</td><td>
<italic>MSY2</italic>
</td><td>
<bold>DbpC</bold>
</td><td>Contrin</td></tr><tr><td>
<italic>YBX3</italic>
</td><td>
<italic>MSY3/MSY4</italic>
</td><td>
<bold>DbpA*</bold>
</td><td>CSDA, ZONAB, oxyR, NF-GMB, YB-2</td></tr><tr><td>
<italic>CARHSP1</italic>
</td><td></td><td>
<bold>CARHSP1</bold>
</td><td>CSDC1, CRHSP-24, CHSP1</td></tr><tr><td>
<italic>CSDC2</italic>
</td><td></td><td>
<bold>PIPPin</bold>
</td><td></td></tr><tr><td>
<italic>CSDE1</italic>
</td><td></td><td>
<bold>UNR*</bold>
</td><td></td></tr><tr><td>
<italic>LIN28A</italic>
</td><td></td><td>
<bold>LIN28A</bold>
</td><td>CSDD1</td></tr><tr><td>
<italic>LIN28B</italic>
</td><td></td><td>
<bold>LIN28B</bold>
</td><td>CSDD2</td></tr></tbody></table><table-wrap-foot><p>The gene names (italics), common names (bold), as well as commonly used alternative names are presented for each protein. Abbreviations are as follows: Y-box binding protein 1, 2, 3 (<italic>YBX1, YBX2, YBX3</italic>), mouse Y-box protein 1, 2, 3, 4 (MSY1, MSY2, MSY3, MSY4), cold shock domain A, B, C1, C2, D1, D2, E1 (CSDA-CSDE1), calcium-regulated heat stable protein 1 (CARHSP1, CHSP1), calcium regulated heat stable protein 24 kDa (CRHSP-24), abnormal cell lineage protein 28 homolog A, B (LIN28A), DNA binding protein A, B, C (DbpA, DbpB, DbpC), Y-box binding protein 1, 2 (YB-1, YB-2), upstream of N-Ras (UNR), nuclease sensitive element binding protein 1 (NSEP1), enhancer factor I subunit A (EF1A, rat), ZO-1-associated nucleic acid-binding protein (ZONAB), oxidative stress regulatory protein (oxyR), nuclear factor that binds the GM-CSF promoter b (NF-GMB). *Alternatively spliced protein: DbpA has two isoforms, which differ by a single domain of ~ 70 amino acids, whereas the UNR isoforms differ by 31 amino acids</p></table-wrap-foot></table-wrap></p>
<p id="Par38">Cold shock proteins were initially identified in bacteria, where a sudden drop in temperature (from 37 °C to 10 °C) induced a 200-fold increase in cold shock protein A (CspA) expression within minutes, which was independent of transcriptional activity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. This rapid inducibility is conserved amongst species [<xref ref-type="bibr" rid="CR7">7</xref>]. A recent study revisited the original observation using genome-wide methods to analyze the global changes occurring in bacteria during the cold shock response [<xref ref-type="bibr" rid="CR8">8</xref>]. The authors identified RNase R and CspA to be the major players. RNase R appears to be responsible for degrading misfolded RNAs, while CspA melts double-stranded RNAs to enable translation.</p>
<p id="Par39">In humans, the predominant group of cold shock domain proteins is denoted the Y-box protein family. The prototypic member is Y-box binding protein-1 (YB-1), also known as DNA binding protein B (DbpB), encoded by the gene <italic>YBX1</italic>. Two additional family members exist, DNA binding protein A (DbpA) and C (DbpC), which are encoded by the genes <italic>YBX3</italic> and <italic>YBX2</italic>, respectively.</p>
<p id="Par40">Whereas <italic>Ybx2</italic> expression is restricted to germ cells [<xref ref-type="bibr" rid="CR9">9</xref>], <italic>Ybx1</italic> and <italic>Ybx3</italic> are ubiquitously expressed during development. However, following birth the expression of <italic>Ybx3</italic> (DbpA) is down-regulated in most tissues, the exceptions being heart, skeletal muscle, blood vessels, and testis [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In humans, two isoforms of DbpA are reported (DbpA_a and DbpA_b), which differ by an alternatively spliced exon that encodes the 69 amino acid long unique domain located adjacent to the CSD [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par41">The <italic>Ybx1</italic> knockout mouse is embryonic lethal indicating an important role during development [<xref ref-type="bibr" rid="CR14">14</xref>]. The <italic>Ybx3</italic> knockout is viable, however the <italic>Ybx1/Ybx3</italic> double knockout shows a more severe developmental phenotype indicating overlapping activities during development [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
<p id="Par42">Another developmentally important cold shock protein expressed in humans is Lin28, which was first characterized as a developmental factor in <italic>C. elegans</italic> [<xref ref-type="bibr" rid="CR16">16</xref>]. However, it was its potential for cellular reprogramming that brought it into the spotlight, as together with Oct3, Sox2, and Nanog, Lin28 is able to revert differentiated cells into their pluripotent state [<xref ref-type="bibr" rid="CR17">17</xref>]. In addition to the cold shock domain, Lin28A/B are unique in that they also possess two CCHC type zinc fingers, which form a knuckle domain that also participates in nucleic acid binding [<xref ref-type="bibr" rid="CR18">18</xref>]. Of particular note is the ability of Lin28 to repress let-7 miRNAs, e.g. thereby regulating glucose metabolism [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. let-7 also targets Lin28 creating a double-negative feedback loop [<xref ref-type="bibr" rid="CR20">20</xref>]. In addition to miRNAs, Lin28 also binds to mRNAs, participating in a number of ribonucleoprotein complexes, such as P-bodies and stress granules, to regulate translation [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
<p id="Par43">A further member of the human cold shock protein family is the calcium-regulated heat-stable protein 1 (CARHSP1); a 24 kDa protein also known as CRHSP-24. Originally identified as a substrate of the calcium/calmodulin-regulated protein phosphatase calcineurin [<xref ref-type="bibr" rid="CR22">22</xref>], CARHSP1 is a paralog of the brain-specific cold shock protein PIPPin [<xref ref-type="bibr" rid="CR23">23</xref>]. CARHSP1 binds to and stabilizes tumor necrosis factor (TNF) mRNA within P-bodies and exosomes [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
<p id="Par44">PIPPin expression is restricted to brain, where it binds mRNA to regulate translation [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR29">29</xref>]. PIPPin is found with ribonucleoprotein complexes, where it interacts with other RNA binding proteins, e.g. hnRNP A1, hnRNP K, and YB-1 [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p id="Par45">The final member of this family is denoted <italic>upstream of N-RAS</italic> (<italic>UNR</italic>) [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. This gene was initially identified as a regulator of N-Ras expression [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. Later it was discovered that <italic>UNR</italic> encodes a protein possessing 5 cold shock domains, which undergoes alternative splicing (see Fig. <xref ref-type="fig" rid="Fig1">1</xref>) [<xref ref-type="bibr" rid="CR37">37</xref>–<xref ref-type="bibr" rid="CR39">39</xref>]; the gene was then renamed <italic>cold shock domain containing E1</italic> (<italic>CSDE1</italic>). Like the other cold shock proteins, UNR/CSDE1 binds single-stranded DNA or RNA [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. UNR works together with the polypyrimidine-tract-binding protein (PTB) to regulate translation and mRNA stability [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. The generation of <italic>Unr</italic> knockout mice demonstrated that, like <italic>Ybx1</italic>, it is essential for mouse development. Further characterization demonstrated that Unr maintains the pluripotent state of embryonic stem cells [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].</p>
<p id="Par46">As mentioned above, cold shock proteins are components of ribonucleoprotein complexes. Two recent studies using proximity biotinylation to map components of the stress granules identified YB-1, DbpA, CSDE1, and Lin28B [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Additionally, CHSP1 (a paralog of PIPPin) was shown to colocalize with G3BP1, an initiator of stress granule formation in human cells [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p>
</sec>
</sec>
<sec id="Sec3">
<title>Cold shock proteins: Thinking in regulatory feedforward and feedback loops</title>
<p id="Par47">Cells undergo stress in many ways, e.g. via interferon release in response to viral infection, the presence of lipopolysaccharide produced by bacteria, or profibrotic factors released by immune cells during inflammation. The binding of these factors to their cell surface receptors activates kinases, which phosphorylate the cold shock proteins; here we use YB-1 as an example (see Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Upon activation, these RNA/DNA chaperones release specific mRNA, thereby enabling a rapid translational response and translocate to the nucleus to regulate gene expression. In many ways this is similar to the unfolded protein response (UPR) observed for heat shock proteins [<xref ref-type="bibr" rid="CR50">50</xref>]. The uptake of YB-1 by cells, which is secreted as an RNA:protein complex [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], uniquely positions this cold shock protein to participate in cellular reprogramming by modulating the expression of numerous target genes. Many of these target genes are themselves known to regulate various aspects of disease both intra- and extracellularly (see Table <xref ref-type="table" rid="Tab2">2</xref>) and can induce cold shock protein expression, e.g. PDGF-B and TGF-β. This is envisioned to result in a feedforward amplification loop that prolongs inflammation, promotes cell proliferation and immune cell infiltration, as well as drives fibrosis, analogous to an avalanche [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Indeed this scenario has recently been documented, supporting our goal for targeted intervention. How this circuit is terminated is unclear, however the development of cold shock protein targeting “neutralizing” antibodies presents one possibility [<xref ref-type="bibr" rid="CR54">54</xref>]. Other potential mechanisms include the inducible proteolytic degradation of YB-1 protein, microRNA-mediated inhibition of YB-1 expression, and the induction of protein tyrosine phosphatase activity to counteract the kinase-mediated phosphorylation/activation that induces nuclear protein translocation [<xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR58">58</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Potential amplification loop for YB-1 in inflammation. (1) Extracellular stimuli (e.g. TGF-β, PDGF-B, LPS) activate cells and induce YB-1 secretion. (2) YB-1 binds to specific membrane associated receptors on the cell surface inducing intracellular signaling cascades that result in kinase activation. YB-1 can also be endocytosed. (3) Activated kinases (e.g. Akt/PKB, ERK, JAK2, RSK) phosphorylate cytoplasmic YB-1 (indicated by the yellow circle), inducing its nuclear translocation. (4) In the nucleus, YB-1 activates the transcription of target genes, as well as induces its own expression and that of DbpA. Cold shock proteins are rapidly induced in response to cell stress, due in part to the existence of preformed complexes of cold shock proteins with their cognate mRNA. (5) Activated cells may also secrete YB-1, which may then act in either an autocrine or paracrine manner. Activated cells may also secrete DbpA via the Golgi. (6) Extracellular YB-1 has mitogenic activity that promotes wound healing/fibrosis. YB-1 also contributes to the recruitment of immune cells to the site of inflammation; directly via its chemoattractant activity or indirectly via the products of its target genes, e.g. CCL5/RANTES. Extracellular activities for DbpA await elucidation. Abbreviations: acetylation (Ac); cold shock domain (CSD); DNA binding protein A (DbpA); lipopolysaccharide (LPS); phosphorylation (P); platelet-derived growth factor B homodimer (PDGF-BB); transforming growth factor beta (TGF-β); tumor necrosis factor (TNF); Y-box binding protein 1 (YB-1)</p></caption><graphic id="MO2" xlink:href="12964_2018_274_Fig2_HTML"></graphic></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Genes regulated by cold shock proteins in disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Protein</th><th>Disease</th><th>Target Cell</th><th>Mode of Action</th><th>Target Gene</th><th>Ref.</th></tr></thead><tbody><tr><td>YB-1</td><td>Sepsis</td><td>neutrophils, macrophages</td><td>N.D.</td><td>Toll-like receptor 4 (TLR4) CXCL-1</td><td>[<xref ref-type="bibr" rid="CR123">123</xref>]</td></tr><tr><td></td><td>T-cell activation Autoimmunity<break></break>Inflammation</td><td>T-helper cells</td><td>binding and stabilization of mRNA</td><td>Interleukin 2 (IL-2)</td><td>[<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR204">204</xref>]</td></tr><tr><td></td><td>Allergic asthma</td><td>activated eosinophils</td><td>stabilization and up-regulation of mRNA transcripts</td><td>GM-CSF</td><td>[<xref ref-type="bibr" rid="CR140">140</xref>]</td></tr><tr><td></td><td></td><td>embryonic lung fibroblasts</td><td>suppression of gene transcription</td><td>GM-CSF</td><td>[<xref ref-type="bibr" rid="CR205">205</xref>]</td></tr><tr><td></td><td>Chronic liver disease</td><td>activated hepatic stellate cells</td><td>induction of expression; antagonizes TGFβ signaling</td><td>Smad7</td><td>[<xref ref-type="bibr" rid="CR153">153</xref>]</td></tr><tr><td></td><td>Chronic liver disease</td><td>rat hepatoma cells (FAO)</td><td>suppression of gene transcription</td><td>Mrp2</td><td>[<xref ref-type="bibr" rid="CR206">206</xref>]</td></tr><tr><td></td><td>Kidney transplant rejection</td><td>primary monocytes</td><td>activation of gene transcription</td><td>RANTES/CCL5</td><td>[<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td></td><td>Kidney transplant rejection</td><td>differentiated macrophages</td><td>suppression of gene transcription</td><td>RANTES/CCL5</td><td>[<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td></td><td>Neointimal hyperplasia Atherosclerosis</td><td>vascular smooth muscle cells</td><td>activation of gene transcription</td><td>RANTES/CCL5</td><td>[<xref ref-type="bibr" rid="CR127">127</xref>]</td></tr><tr><td></td><td>Endometriosis</td><td>peritoneal macrophages</td><td>activation of gene transcription and recruitment of inflammatory cells</td><td>RANTES/CCL5*</td><td>[<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR208">208</xref>]</td></tr><tr><td></td><td>Chronic kidney disease Interstial kidney disease</td><td>proximal tubular cells</td><td>control of translation</td><td>TGFβ</td><td>[<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]</td></tr><tr><td></td><td>Mesangioproliferative glomerulonephritis</td><td>endothelial cells</td><td>gene transcription</td><td>PDGF-B</td><td>[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td></td><td>Mesangioproliferative glomerulonephritis</td><td>renal cells</td><td>gene transcription, secretion</td><td>PDGF-B</td><td>[<xref ref-type="bibr" rid="CR138">138</xref>]</td></tr><tr><td></td><td>Tubulointerstial nephritis</td><td>renal cells, macrophages</td><td>gene transcription, secretion, differentiation, phagocytosis</td><td>RANTES/CCL5 MCP-1/CCL2 IL-10</td><td>[<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR203">203</xref>]</td></tr><tr><td></td><td>Dysregulated angiogenesis</td><td></td><td>repression of VEGF promotor</td><td>VEGF</td><td>[<xref ref-type="bibr" rid="CR210">210</xref>]</td></tr><tr><td></td><td>Calcineurin inhibitor mediated kidney fibrosis</td><td>mesangial cells</td><td>binding and stabilization of mRNA</td><td>Collagen</td><td>[<xref ref-type="bibr" rid="CR136">136</xref>]</td></tr><tr><td></td><td>Anti-Thy1.1 nephritis</td><td>mesangial cells</td><td>gene transcription, secretion</td><td>Notch-3</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td></td><td>Type II diabetes</td><td>skeletal muscle</td><td>gene transcription, signal pathways</td><td>PTP1B</td><td>[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td></td><td>T-ALL</td><td>T cell</td><td>Cell cycle</td><td>Cdk6</td><td>[<xref ref-type="bibr" rid="CR181">181</xref>]</td></tr><tr><td>CHSP1</td><td>Inflammation Sepsis</td><td>macrophages</td><td>enhancement of mRNA stability</td><td>TNF</td><td>[<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr><tr><td>DbpA</td><td>Dysregulated angiogenesis</td><td>fibroblasts</td><td>repression of VEGF promoter</td><td>VEGF</td><td>[<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]</td></tr><tr><td></td><td>Hepatocellular carcinoma</td><td>hepatocytes</td><td></td><td></td><td>[<xref ref-type="bibr" rid="CR211">211</xref>–<xref ref-type="bibr" rid="CR214">214</xref>]</td></tr><tr><td></td><td>Mesangioproliferative glomerulonephritis</td><td>renal cells</td><td>gene transcription, secretion</td><td>DbpA</td><td>[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr></tbody></table><table-wrap-foot><p>For the studied cold shock domain proteins, the disease, target cell, mode of action, and target genes are listed, together with the relevant citation. In sepsis, the mode of action has not been determined (N.D.). Modified from Lindquist et al. [<xref ref-type="bibr" rid="CR4">4</xref>].</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Cold shock proteins function in the cellular response to stress</title>
<p id="Par48">Components of stress granules and P-bodies have been implicated in the cellular stress response [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Under ‘normal’ conditions, stress granules form when translation initiation is stalled. The RNA binding proteins G3BP1 or TIA-1 are key components of stress granule formation, as they possess the ability for self-association. Over-expression of either protein has been shown to induce stress granule formation even in the absence of stress [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Using mRNA as a scaffold, these proteins form homo- or hetero-oligomeric ribonucleoprotein complexes; self-assembly is mediated by intrinsically disordered regions (IDRs) within the RNA binding protein(s); also referred to as low complexity regions [<xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR68">68</xref>]. Several genetic mutations associated with neurodegenerative diseases have been identified that influence the self-assembly of RNA binding proteins (e.g. <italic>transactive response DNA-binding protein (TDP-43)</italic> and <italic>fused in sarcoma/translocated in liposarcoma (FUS/TLS)</italic>). Both are known to form prion-like protein aggregates; an activity attributed to their low complexity regions [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. The more we learn about the molecular mechanisms underlying protein aggragation diseases, the greater the number of RNA binding proteins identified [<xref ref-type="bibr" rid="CR69">69</xref>–<xref ref-type="bibr" rid="CR71">71</xref>]. The mutations identified within these diseaseassociated proteins typically favor cytoplasmic localization, facilitate protein aggregation, or prevent granulophagy; the clearance of stress granules by autophagosomes [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. Recently, the expansion of intronic GGGGCC repeats within C9ORF72 was identified as a common cause of ALS/FTD [<xref ref-type="bibr" rid="CR73">73</xref>]. C9ORF72 interacts with endosomes and is required for normal vesicle trafficking, therefore the loss of C9ORF72 observed with G4-repeat expansion may affect granulophagy. Alternatively, the G4-repeats of C9ORF72 have been proposed to inhibit the neuroprotective effects mediated by tiRNAs binding to the cold shock domain of YB-1 [<xref ref-type="bibr" rid="CR74">74</xref>].</p>
<p id="Par49">As a known component of stress granules, YB-1 also possesses the ability for self-assembly [<xref ref-type="bibr" rid="CR75">75</xref>]. YB-1 has been shown to form amyloid-like fibrils, an activity attributed to its C-terminal domain, which is composed of alternating regions of positive or negatively charged amino acids that form a zipper-like structure as well as contributes to its RNA binding activity [<xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR81">81</xref>]. Interestingly, the oligomerization of YB-1 is induced by a select set of RNAs [<xref ref-type="bibr" rid="CR79">79</xref>]. In the context of neurodegeneration, YB-1 and G3BP1 have been shown to compete with TDP-43 and FUS for mRNA binding and thereby induce the release of prion-like protein aggregates that have formed [<xref ref-type="bibr" rid="CR82">82</xref>]. To complicate matters further, in human sarcoma YB-1 activates <italic>G3BP1</italic> mRNA thereby controlling both the expression levels of G3BP1 and the subsequent nucleation of stress granule formation [<xref ref-type="bibr" rid="CR83">83</xref>]. Indeed cold shock is one trigger of stress granule assembly in mammals [<xref ref-type="bibr" rid="CR84">84</xref>]. Stress granules have been implicated in the pathophysiology for a number of neurodegenerative diseases, including Alzheimer’s, amyotrophic lateral sclerosis (ALS), fronto-temporal dementia (FTD), spinocerebellar ataxia (SCA), and Huntington’s disease [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Here we propose possible mechanisms where cold shock proteins may play a critical role in the pathophysiology of these diseases. When granulophagy is defective either due to an inability to degrade protein aggregates or to system overload, i.e. when the rate of production exceeds degradation, stress granules that would normally undergo autophagy become lysosomes [<xref ref-type="bibr" rid="CR64">64</xref>]. The autophagic pathway intersects with both the classical and the unconventional pathways of protein secretion [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. YB-1 is secreted via a non-classical pathway involving ATP-binding cassette transporters and microvesicles, as well as post-translational modification of two C-terminal lysine residues (K301/K304) [<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. Non-canonical K27-linked ubiquitination of YB-1 was shown to be required for its interaction with tumor susceptibility gene 101 (TSG101), a component of multivesicular bodies (MVBs) [<xref ref-type="bibr" rid="CR90">90</xref>]. Fusion of MVB with the plasma membrane is required for the release of exosomes [<xref ref-type="bibr" rid="CR91">91</xref>]. Since YB-1 is a component of exosomes, required for the sorting of mRNAs [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR94">94</xref>], it remains to be determined whether stress granule clearance coincides with the pathway of exosome formation and YB-1 secretion. If these pathways are indeed one in the same, does this apply to both cytoplasmic and nuclear stress granules? Should this hypothesis hold true for YB-1, it will be of interest to see whether it also applies to other cold shock proteins, such as DbpA or CSDE1, that have already been identified as components of both stress granules and exosomes [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>].</p>
</sec>
<sec id="Sec5">
<title>Cold shock proteins in disease</title>
<p id="Par50">The decisive data for a causal relationship between cold shock proteins and disease comes from cancer. The role of YB-1 as an oncoprotein was secured when it was demonstrated that 100% of YB-1 transgenic mice over-expressing the protein developed invasive tumors [<xref ref-type="bibr" rid="CR97">97</xref>]. YB-1 and DbpA expression is upregulated in cancer and nuclear localization indicates a poor prognosis [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. In the nucleus, cold shock proteins bind to single- and double-stranded DNA and serve as transcriptional regulators. In tumors, nuclear YB-1 correlates with enhanced expression of the multidrug resistance protein 1 (MDR1) [<xref ref-type="bibr" rid="CR99">99</xref>–<xref ref-type="bibr" rid="CR105">105</xref>]. Cells in which YB-1 expression has been ablated using small inhibitory RNA fail to proliferate and were recently shown to prevent tumor growth by disrupting angiogenesis [<xref ref-type="bibr" rid="CR106">106</xref>].</p>
<p id="Par51">YB-1 can also be secreted [<xref ref-type="bibr" rid="CR88">88</xref>]. Acetylation and ubiquitination of YB-1 have both been shown to play roles in regulating secretion as well as intracellular stability [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. YB-1 can be proteolytically cleaved and extracellular YB-1, and/or fragments thereof, is found in the serum of patients, binds to cell surface receptors, and exerts extracellular activities, e.g. enhancing proliferation and induces migration of immune cells [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR109">109</xref>–<xref ref-type="bibr" rid="CR114">114</xref>].</p>
<p id="Par52">Serum YB-1 levels are increased in cancer patients and the occurrence of extracellular YB-1 or its fragments may serve as a useful marker for cancer, as ~ 80% of patients tested positive for the YB-1/p18 fragment, whereas inflammatory diseases did not correlate with positive results [<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR112">112</xref>–<xref ref-type="bibr" rid="CR115">115</xref>].</p>
<p id="Par53">Lin28 reactivation is also found in a number of cancers, where Lin28 appears to contribute to the formation of cancer stem cells [<xref ref-type="bibr" rid="CR18">18</xref>]. The role of Lin28 in cancer has been extensively reviewed elsewhere [<xref ref-type="bibr" rid="CR116">116</xref>]. Similar to Lin28, <italic>Unr</italic> also regulates the differentiation state of cells [<xref ref-type="bibr" rid="CR44">44</xref>]. Due to its ability to regulate the expression of several proto-oncogenes, <italic>UNR</italic> has also been investigated in cancer [<xref ref-type="bibr" rid="CR117">117</xref>–<xref ref-type="bibr" rid="CR119">119</xref>]. In prostate cancer, a novel regulatory activity of <italic>HEPSIN</italic> on <italic>UNR</italic> was identified [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR121">121</xref>]. <italic>UNR</italic> expression levels have also been demonstrated as a prognostic biomarker for survival in pancreatic ductal adenocarcinoma [<xref ref-type="bibr" rid="CR122">122</xref>].</p>
<p id="Par54">For inflammatory and fibrotic diseases, the data for the role of cold shock proteins appears more associative. The initial data came from animal studies on <italic>Ybx1</italic> heterozygous mice, which express only half the amount of YB-1 compared to wild type. The induction of disease in experimental models such as sterile sepsis or unilateral ureter obstruction identified non-redundant roles for YB-1 in the development of inflammation and fibrosis [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]. These activities are mediated in part by YB-1-dependent gene regulation of pro-inflammatory factors (PDGF-B, VEGF, IL-2, GM-CSF, EGF, TGF-β, CCL2, CCL5, and CXCR4) [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR125">125</xref>–<xref ref-type="bibr" rid="CR134">134</xref>] as well as fibrosis-related genes (<italic>MMP2</italic>, <italic>Col1a1</italic>, and <italic>Col2a1</italic>) (see Table <xref ref-type="table" rid="Tab2">2</xref>) [<xref ref-type="bibr" rid="CR135">135</xref>–<xref ref-type="bibr" rid="CR137">137</xref>]. In mesangioproliferative glomerulonephritis, cold shock protein expression is clearly induced; an effect mediated by PDGF-B, and regulates mesangial cell proliferation [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR138">138</xref>]. In atherosclerosis, YB-1 contributes to neointima formation by modulating CCL5 expression [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]. In asthma, YB-1 promotes eosinophil survival by stabilizing granulocyte macrophage-colony-stimulating factor mRNA [<xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]. Successful approaches to ameliorate diseases by targeting YB-1 activities have been demonstrated [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR142">142</xref>–<xref ref-type="bibr" rid="CR146">146</xref>].</p>
</sec>
<sec id="Sec6">
<title>From molecules to intervention strategies: Rationale for cold shock protein targeting</title>
<p id="Par55">We propose that cold shock proteins represent verifiable targets for therapeutic intervention and envision strategies aimed at targeting cold shock proteins directly or targeting cold shock protein-dependent mechanisms. This goal is supported by the following observations that link the prototypic cold shock protein YB-1 with other key molecule activities. For the latter, intervention strategies have already proven to be successful.<list list-type="order"><list-item><p id="Par56">YB-1 regulates NF-κB activation. In the absence of YB-1, NF-κB activation is defective [<xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR148">148</xref>].</p></list-item><list-item><p id="Par57">YB-1 regulates IL-2 production. CD28 co-stimulation is required for T cell activation and the induction of autocrine IL-2 production. CD28 signals stabilize IL-2 mRNA. YB-1 is one of the essential RNA binding proteins that mediate this activity [<xref ref-type="bibr" rid="CR129">129</xref>].</p></list-item><list-item><p id="Par58">YB-1 interacts with p53. Nuclear YB-1 regulates p53 function by inhibiting its ability to induce apoptosis, however it does not influence p53’s regulation of cell cycle [<xref ref-type="bibr" rid="CR149">149</xref>–<xref ref-type="bibr" rid="CR151">151</xref>].</p></list-item><list-item><p id="Par59">YB-1 and TGF-β counter-regulate one another. It was recently demonstrated that TGF-β induces miR-216a, which suppresses YB-1 expression. YB-1 suppresses Tsc22, which serves as an enhancer for <italic>Col1a2</italic> expression [<xref ref-type="bibr" rid="CR152">152</xref>]. Additionally, we have shown that YB-1 mediates the anti-fibrotic effect of interferon-gamma, directly competes for Smad3 binding to p300/CBP [<xref ref-type="bibr" rid="CR153">153</xref>].</p></list-item></list></p>
<p id="Par60">Molecular pathways are not per se pathological, but rather part of regulatory networks. A prolonged or permanent dysregulation results in diseases, especially those of an inflammatory or malignant nature. Developing targeted therapies requires insight into the molecular pathways of underlying diseases, as pivotal cell decisions are dependent on the “activation” of key molecules. Examples of such molecules are provided in the following.</p>
<sec id="Sec7">
<title>NF-κB; diseases: Cancer, inflammatory, and autoimmune</title>
<p id="Par61">Nuclear factor binding near the kappa-light-chain gene in B cells (NF-κB) are a family of inducible transcription factors that control inflammatory gene expression [<xref ref-type="bibr" rid="CR154">154</xref>–<xref ref-type="bibr" rid="CR157">157</xref>]. In many cancers, NF-κB is constitutively active and localized to the nucleus. Therefore many anti-tumor therapies seek to block NF-κB activity as a means to inhibit tumor growth or to sensitize tumor cells to conventional therapies, such as chemotherapy. The extensive involvement of NF-κB in inflammation and disease has also established it as a therapeutic target. Indeed, many common synthetic (e.g., aspirin, ibuprofen, glucocorticoids) and traditional medicines (e.g., green tea, curcumin) target the NF-κB pathway. To date, over 800 compounds have been shown to inhibit NF-κB signaling (such as anatabine, disulfiram, dithiocarbamates, olmesartan). Many natural products (including anti-oxidants) that have been promoted to have anti-cancer and anti-inflammatory activity have also been shown to inhibit NF-κB.</p>
</sec>
<sec id="Sec8">
<title>IL-2; diseases: Autoimmune and organ transplantation; cancer, viral infection, and vaccination</title>
<p id="Par62">Interleukin-2 (IL-2) is essential for lymphocyte survival, differentiation, and proliferation [<xref ref-type="bibr" rid="CR158">158</xref>–<xref ref-type="bibr" rid="CR161">161</xref>]. Therefore, many immunosuppressive drugs (such as corticosteroids, cyclosporine A, and tacrolimus) used to treat autoimmune diseases or suppress graft rejection work by inhibiting the production of IL-2 by antigen-activated T cells. Sirolimus blocks intracellular IL-2R signaling, thereby preventing the clonal expansion of activated T cells. The extracellular effects of IL-2 are abrogated by monoclonal antibody application. The use of antibody induction after kidney transplantation has increased to 60% in the past decade and roughly one half of the induction agent used is anti-interleukin-2 receptor alpha antibody (IL-2RA, i.e. basiliximab or daclizumab). In combination with calcineurin inhibitors, IL-2RAs have been shown to reduce the incidence of acute rejection without increasing risks of infections or malignancies in kidney transplantation.</p>
<p id="Par63">Recombinant IL-2 has been approved for the treatment of cancers (malignant melanoma, renal cell cancer) and has been tested in clinical trials for the treatment of chronic viral infections, and as an adjuvant for vaccines.</p>
</sec>
<sec id="Sec9">
<title>p53; disease: Cancer</title>
<p id="Par64">Tumor protein p53 (p53) is a tumor suppressor and the most frequently mutated gene in human cancers [<xref ref-type="bibr" rid="CR162">162</xref>–<xref ref-type="bibr" rid="CR165">165</xref>]. People who possess only one functional copy of the p53 gene have a higher incidence of tumor development. The p53 gene can also be damaged by chemical mutagenesis or radiation, as well as p53 protein inactivated by viruses (e.g. human papillomavirus). p53 itself does not bind to DNA, but rather exerts its influence via its complex interactions with transcription factors and regulators. p53 mutants are associated with changes in chromatin structure, leading to genetic instability and alterations in cell cycle regulation as well as cellular metabolism. Mutant p53 has been shown to act downstream of the TNF receptor to prolong and enhance NF-κB activation thereby driving tumor-promoting inflammation and enhancing chemokine secretion. The p53 pathway inhibitors nutlin and PRIMA-1 reactivate p53 function, enhancing its anti-proliferative activity and thereby sensitizing cancer cells to apoptosis [<xref ref-type="bibr" rid="CR166">166</xref>].</p>
</sec>
<sec id="Sec10">
<title>TGF-β; diseases: Organ fibrosis, cancer, immune suppression</title>
<p id="Par65">Transforming growth factor-β (TGF-β) promotes fibroblast proliferation, differentiation, and survival. In addition to inducing cytokine secretion, TGF-β upregulates the synthesis of collagens and extracellular matrix, making it a therapeutic target in fibrotic diseases [<xref ref-type="bibr" rid="CR167">167</xref>]. TGF-β also induces the epithelial-mesenchymal xtransition (EMT); an important step in tumor progression, thus making it a target for anti-cancer therapy [<xref ref-type="bibr" rid="CR168">168</xref>]. Strategies to target TGF-β include neutralizing monoclonal antibodies targeting TGF-β, monoclonal antibodies targeting the integrin α<sub>v</sub>β<sub>6</sub> are aimed at preventing the activation of latent TGF-β, and small molecules targeting TGF-β receptor activity. Additionally, some commonly used drugs, e.g. the kinase inhibitor imatinib mesylate, appear to also block TGF-β activities and abrogate fibrotic responses [<xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR170">170</xref>]. However, inhibiting TGF-β can also have unwanted effects, such as enhanced immune cell activation (due to the loss of TGF-β-mediated inhibition), hindering implantation during pregnancy, and impaired wound healing (within a normal response to injury).</p>
</sec>
</sec>
<sec id="Sec11">
<title>Outlook</title>
<sec id="Sec12">
<title>Diagnostics and therapy with interventions targeting cold shock proteins</title>
<p id="Par66">Cold shock protein expression is a suitable biomarker for diverse disease activities [<xref ref-type="bibr" rid="CR112">112</xref>–<xref ref-type="bibr" rid="CR114">114</xref>]. The presence of extracellular cold shock proteins, and/or fragments thereof, may serve diagnostic purposes. Beyond their diagnostic potential, we envision that therapeutic interventions targeting cold shock proteins may reduce disease burden, as YB-1 is expected to target pathways distinct from those targeted by current therapies. Therefore, we anticipate at least in some cases synergistic activity with existing therapies.</p>
<p id="Par67">At present cold shock protein research is on the verge of entering clinical trials in different fields, especially for advanced cancer disease (ongoing trials adopt a vaccination strategy against YB-1 epitope in HER2-negative stage III-IV breast cancer or an oncolytic virotherapy in bladder cancer). In experimental disease models intervention strategies targeting YB-1 reduced inflammation and organ fibrosis [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR142">142</xref>, <xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR171">171</xref>]. HSc025 was identified in a natural products screen for compounds that suppressed collagen gene expression, i.e. fibrosis [<xref ref-type="bibr" rid="CR172">172</xref>]. HSc025 promotes nuclear translocation of YB-1, which acts as a suppressor of the gene <italic>COL1A2</italic> (<italic>collagen type I alpha 2</italic>) thereby reducing fibrosis [<xref ref-type="bibr" rid="CR137">137</xref>, <xref ref-type="bibr" rid="CR142">142</xref>, <xref ref-type="bibr" rid="CR153">153</xref>, <xref ref-type="bibr" rid="CR171">171</xref>, <xref ref-type="bibr" rid="CR173">173</xref>–<xref ref-type="bibr" rid="CR175">175</xref>].</p>
<p id="Par68">Another compound is the natural product fisetin (3,7,3′,4′-tetrahydroxyflavone); a polyphenolic compound found in plants, also called a flavonoid, that demonstrated anti-cancer as well as anti-inflamatory activity [<xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR177">177</xref>]. Fisetin blocks the Akt-mediated phosphorylation of Ser<sup>102</sup> within the CSD [<xref ref-type="bibr" rid="CR144">144</xref>, <xref ref-type="bibr" rid="CR178">178</xref>]. However, an inhibition of p70S6K, a member of the ribosomal S6 kinase (RSK) family, has also been reported [<xref ref-type="bibr" rid="CR179">179</xref>]. Molecular modeling proposed that fisetin binds to the CSD of YB-1; if such binding prevents YB-1 from being phosphorylated then this proposal would unify these reports, as both kinases phosphorylate Ser<sup>102</sup> [<xref ref-type="bibr" rid="CR144">144</xref>, <xref ref-type="bibr" rid="CR180">180</xref>, <xref ref-type="bibr" rid="CR181">181</xref>]. Regardless of the mechanism of action, fisetin prevents the nuclear translocation of YB-1 by preventing phosphorylation of the CSD.</p>
</sec>
</sec>
<sec id="Sec13">
<title>Developing topics in the cold shock protein field</title>
<p id="Par69">Pro-inflammatory factors, like TNF, activate NF-κB, which induces miR-155 expression. Increased miR-155 suppresses CARHSP1, which stabilizes TNF mRNA; thus, this negative feedback loop relieves chronic inflammation and was shown to play a protective role during atherosclerosis [<xref ref-type="bibr" rid="CR182">182</xref>].</p>
<p id="Par70">The modulation of tumor necrosis factor receptor signaling by extracellular cold shock proteins is relevant to a number of diseases, including preeclampsia, diabetic nephropathy, systemic lupus erythematosus, liver fibrosis, and infectious diseases where TNF plays a central role in disease pathology [<xref ref-type="bibr" rid="CR183">183</xref>]. Additionally, TNF promotes expansion of JAK2V617F positive cells in myeloproliferative neoplasms [<xref ref-type="bibr" rid="CR184">184</xref>]. Extracellular cold shock proteins are also topics of interest, as is their potential role in fetal-maternal communication during implantation.</p>
<p id="Par71">Receptor Notch-3 is a developmental receptor that plays an important role in stem cell maintenance as well as in cell differentiation. Known roles include the development thymocytes as well as hepatocellular carcinoma. Strong expression is also found in the placenta and uterus suggesting an important role in pregnancy. Extracellular YB-1 serves as a noncanonical ligand for receptor Notch-3 and therefore its ability to modulate receptor Notch-3 signaling is of relevance [<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. Progranulin has recently been demonstrated as a Notch ligand [<xref ref-type="bibr" rid="CR185">185</xref>] and therefore YB-1/progranulin may also modulate Notch signaling, which may be of relevance in a number of diseases, e.g. diabetic nephropathy, systemic lupus erythematosus, liver fibrosis, and infectious disease.</p>
<p id="Par72">The participation of extracellular cold shock proteins in inter-organ communication is another important emerging idea (i.e. endocrine activity). Liver-kidney interactions have recently been described for nonalcoholic fatty liver disease (NAFLD) [<xref ref-type="bibr" rid="CR186">186</xref>]. Here, the liver is an important source of pro-inflammatory cytokines, which modulate inflammation and renal injury [<xref ref-type="bibr" rid="CR187">187</xref>, <xref ref-type="bibr" rid="CR188">188</xref>]. Chronic kidney disease induces intestinal dysbiosis, which contributes to systemic inflammation (via the production of uremic toxins) thereby promoting NAFLD. Inflammation also drives renal fibrosis, which further reduces kidney function, in so doing enhances the levels of uremic toxins within the blood, creating a self-perpetuating multiorgan disease [<xref ref-type="bibr" rid="CR189">189</xref>]. Several pro-inflammatory cytokines as well as bacterial toxins, e.g. lipopolysaccharide, induce cold shock protein secretion, which binds to TNF receptors and receptor Notch-3 [<xref ref-type="bibr" rid="CR89">89</xref>]. Therefore we believe that extracellular cold shock proteins are intimately involved in this cycle.</p>
<p id="Par73">Finally, evidence is emerging that cold shock proteins may regulate the formation of protein aggregates in neurodegenerative diseases [<xref ref-type="bibr" rid="CR82">82</xref>]. The role of exosomes in the spreading of neurodegenerative and prion diseases is well documented [<xref ref-type="bibr" rid="CR190">190</xref>–<xref ref-type="bibr" rid="CR192">192</xref>]. However, it remains to be determined whether stress granules do indeed serve as precursors for exosomes and if so, to what extent they contribute to the spread of neurodegenerative diseases versus the detoxification of cells by removing protein aggregates or perhaps both. Additionally, it remains to be shown whether the targeting of cold shock proteins in this context might be of therapeutic benefit.</p>
<p id="Par74">Since many components of stress granules and P-bodies are also targets of autoantibodies, the question remains as to whether this pathway contributes to the generation of autoantibodies against YB-1 [<xref ref-type="bibr" rid="CR193">193</xref>–<xref ref-type="bibr" rid="CR196">196</xref>]. Certainly the RNA:protein complexes described as “beads on a string” possess the essential elements (i.e. multiple repeating epitopes) required for the successful activation of B-cells [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR197">197</xref>].</p>
</sec>
<sec id="Sec14">
<title>Post-translational modifications of cold shock proteins</title>
<p id="Par75">The number of post-translational modifications identified within cold shock proteins is continually growing [<xref ref-type="bibr" rid="CR198">198</xref>]. A recent paper described O-GlcNAcylation of YB-1; a post-translational modification linking nutrient and stress sensing to transcriptional and translational regulation [<xref ref-type="bibr" rid="CR199">199</xref>, <xref ref-type="bibr" rid="CR200">200</xref>]. This novel modification was shown to contribute to the oncogenic potential of YB-1 in hepatocellular carcinoma (HCC) and appears to exert its activity within the nucleus, since it also requires phosphorylation of Ser102 within the CSD. O-GlcNAcylation is mediated by the enzyme O-GlcNAc transferase (OGT), which is known to promote liver cancer as well as a number of diseases, such as diabetes and neurodegeneration [<xref ref-type="bibr" rid="CR200">200</xref>, <xref ref-type="bibr" rid="CR201">201</xref>]. Since O-GlcNAcylation of NF-κB potentiates its acetylation [<xref ref-type="bibr" rid="CR202">202</xref>], it will be interesting to see whether a similar effect is also found for the acetylation of YB-1. As you see from this example, there is still much work to be done in linking a particular post-translational modification to specific protein activities. To extrapolate this idea further, it remains to be seen whether there are cell-specific modifications or activities of the cold shock proteins and whether these apply to particular compartments within the cell (e.g. nucleus, mitochondria, exosomes, etc.). Here, it is anticipated that CRISPR/Cas technology will help in creating and characterizing cell lines with specific point mutations targeting a particular modified amino acid. However, there is still much work to be done in identifying and characterizing cell-specific activities of the cold shock proteins. Our recent study demonstrating cell-specific activities of YB-1 in monocytes and macrophages is likely merely the tip of the iceberg [<xref ref-type="bibr" rid="CR203">203</xref>]. There are still numerous organs, cell types, and cell subsets (e.g. Th1 versus Th2 cells) awaiting characterization. Therefore strategies aimed at deleting <italic>Ybx1</italic> in specific tissues and/or cell types must consider possible developmental effects when characterizing the phenotypes of such cells. Add to this the presence of cold shock proteins within exosomes and thus their extracellular activities and we have a long road ahead to fully understand the complex behavior and activities of these fascinating proteins in both health and disease. Here, the application of high-throughput <italic>omics</italic> technologies will be essential to keep track of the changes going on within such cells on both the transcriptional as well as translational levels.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Ac</term>
<def>
<p id="Par3">Acetylation</p>
</def>
</def-item>
<def-item>
<term>CARHSP1</term>
<def>
<p id="Par4">Calcium-regulated heat-stable protein 1</p>
</def>
</def-item>
<def-item>
<term>CBP</term>
<def>
<p id="Par5">CREB-binding protein</p>
</def>
</def-item>
<def-item>
<term>CCL2</term>
<def>
<p id="Par6">Chemokine (C-C motif) ligand 2</p>
</def>
</def-item>
<def-item>
<term>CCL5</term>
<def>
<p id="Par7">Chemokine (C-C motif) ligand 5</p>
</def>
</def-item>
<def-item>
<term>CRHSP-24</term>
<def>
<p id="Par8">Calcium-regulated heat-stable protein of 24 kDa</p>
</def>
</def-item>
<def-item>
<term>CSD</term>
<def>
<p id="Par9">Cold shock domain</p>
</def>
</def-item>
<def-item>
<term>CspA</term>
<def>
<p id="Par10">Cold shock protein A</p>
</def>
</def-item>
<def-item>
<term>CXCR4</term>
<def>
<p id="Par11">C-X-C motif chemokine receptor 4</p>
</def>
</def-item>
<def-item>
<term>DbpA</term>
<def>
<p id="Par12">DNA binding protein A</p>
</def>
</def-item>
<def-item>
<term>DbpB</term>
<def>
<p id="Par13">DNA binding protein B</p>
</def>
</def-item>
<def-item>
<term>DbpC</term>
<def>
<p id="Par14">DNA binding protein C</p>
</def>
</def-item>
<def-item>
<term>EGF</term>
<def>
<p id="Par15">Epidermal growth factor</p>
</def>
</def-item>
<def-item>
<term>EMT</term>
<def>
<p id="Par16">Epithelial-mesenchymal transition</p>
</def>
</def-item>
<def-item>
<term>FUS/TLS</term>
<def>
<p id="Par17">Fused in sarcoma/translocated in liposarcoma</p>
</def>
</def-item>
<def-item>
<term>GM-CSF</term>
<def>
<p id="Par18">Granulocyte-macrophage colony-stimulating factor</p>
</def>
</def-item>
<def-item>
<term>HER2</term>
<def>
<p id="Par19">Human epidermal growth factor receptor 2</p>
</def>
</def-item>
<def-item>
<term>hnRNP</term>
<def>
<p id="Par20">Heterogeneous nuclear ribonucleoprotein</p>
</def>
</def-item>
<def-item>
<term>IL-2</term>
<def>
<p id="Par21">Interleukin-2</p>
</def>
</def-item>
<def-item>
<term>IL-2RA</term>
<def>
<p id="Par22">Interleukin-2 receptor alpha</p>
</def>
</def-item>
<def-item>
<term>JAK</term>
<def>
<p id="Par23">Janus kinase</p>
</def>
</def-item>
<def-item>
<term>LPS</term>
<def>
<p id="Par24">Lipopolysaccharide</p>
</def>
</def-item>
<def-item>
<term>MDR1</term>
<def>
<p id="Par25">Multidrug resistance protein 1</p>
</def>
</def-item>
<def-item>
<term>mRNA</term>
<def>
<p id="Par26">Messenger RNA</p>
</def>
</def-item>
<def-item>
<term>NAFLD</term>
<def>
<p id="Par27">Nonalcoholic fatty liver disease</p>
</def>
</def-item>
<def-item>
<term>NF-κB</term>
<def>
<p id="Par28">Nuclear factor binding near the kappa-light-chain gene in B cells</p>
</def>
</def-item>
<def-item>
<term>PDGF-B</term>
<def>
<p id="Par29">Platelet-derived growth factor subunit B</p>
</def>
</def-item>
<def-item>
<term>TDP-43</term>
<def>
<p id="Par30">transactive response DNA-binding protein</p>
</def>
</def-item>
<def-item>
<term>TGF-β</term>
<def>
<p id="Par31">Transforming growth factor beta</p>
</def>
</def-item>
<def-item>
<term>TNF</term>
<def>
<p id="Par32">Tumor necrosis factor</p>
</def>
</def-item>
<def-item>
<term>UNR</term>
<def>
<p id="Par33">Upstream of N-Ras</p>
</def>
</def-item>
<def-item>
<term>UPR</term>
<def>
<p id="Par34">Unfolded protein response</p>
</def>
</def-item>
<def-item>
<term>VEGF</term>
<def>
<p id="Par35">Vascular endothelial growth factor</p>
</def>
</def-item>
<def-item>
<term>YB-1</term>
<def>
<p id="Par36">Y-box binding protein-1</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank Dr. Sabine Brandt for helpful discussion.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par76">This work was supported by the Deutsche Forschungsgemeinschaft (DFG): SFB 854, project A01, grants ME-1365/7–2 and ME-1365/9–1 to PRM, and LI-1031/4–1 to JAL.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>JAL and PRM wrote and edited the manuscript. Both authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar2">
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar3">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests</p>
</sec>
<sec id="FPar5">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolffe</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Tafuri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ranjan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Familari</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man</article-title>
<source/>New Biol
          <year>1992</year>
<volume>4</volume>
<issue>4</issue>
<fpage>290</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">1622927</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolffe</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins</article-title>
<source/>BioEssays
          <year>1994</year>
<volume>16</volume>
<issue>4</issue>
<fpage>245</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1002/bies.950160407</pub-id>
<pub-id pub-id-type="pmid">8031301</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Inouye</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The cold-shock response--a hot topic</article-title>
<source/>Mol Microbiol
          <year>1994</year>
<volume>11</volume>
<issue>5</issue>
<fpage>811</fpage>
<lpage>818</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.1994.tb00359.x</pub-id>
<pub-id pub-id-type="pmid">8022259</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>The role of cold shock domain proteins in inflammatory diseases</article-title>
<source/>J Mol Med (Berl).
          <year>2014</year>
<volume>92</volume>
<issue>3</issue>
<fpage>207</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1007/s00109-014-1136-3</pub-id>
<pub-id pub-id-type="pmid">24562821</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schreiter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kadereit</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Michele</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pabst</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Cold shock Y-box protein-1 participates in signaling circuits with auto-regulatory activities</article-title>
<source/>Eur J Cell Biol
          <year>2012</year>
<volume>91</volume>
<issue>6–7</issue>
<fpage>464</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2011.07.002</pub-id>
<pub-id pub-id-type="pmid">21962637</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gottesman</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Chilled in translation: adapting to bacterial climate change</article-title>
<source/>Mol Cell
          <year>2018</year>
<volume>70</volume>
<issue>2</issue>
<fpage>193</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2018.04.003</pub-id>
<pub-id pub-id-type="pmid">29677488</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graumann</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Marahiel</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>A superfamily of proteins that contain the cold-shock domain</article-title>
<source/>Trends Biochem Sci
          <year>1998</year>
<volume>23</volume>
<issue>8</issue>
<fpage>286</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="doi">10.1016/S0968-0004(98)01255-9</pub-id>
<pub-id pub-id-type="pmid">9757828</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Burkhardt</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Rouskin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>A stress response that monitors and regulates mRNA structure is central to cold shock adaptation</article-title>
<source/>Mol Cell
          <year>2018</year>
<volume>70</volume>
<issue>2</issue>
<fpage>274</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.035</pub-id>
<pub-id pub-id-type="pmid">29628307</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snyder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Soundararajan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dearth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Compound heterozygosity for Y box proteins causes sterility due to loss of translational repression</article-title>
<source/>PLoS Genet
          <year>2015</year>
<volume>11</volume>
<issue>12</issue>
<fpage>e1005690</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005690</pub-id>
<pub-id pub-id-type="pmid">26646932</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berghella</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De Angelis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De Buysscher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mortazavi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Biressi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Forcales</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Sirabella</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cossu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle</article-title>
<source/>Genes Dev
          <year>2008</year>
<volume>22</volume>
<issue>15</issue>
<fpage>2125</fpage>
<lpage>2138</lpage>
<pub-id pub-id-type="doi">10.1101/gad.468508</pub-id>
<pub-id pub-id-type="pmid">18676817</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Parreira</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Devuyst</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Caplanusi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>N'Kuli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marien</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Van Der Smissen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Verroust</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Terzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Matter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Balda</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Pierreux</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Courtoy</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells</article-title>
<source/>J Am Soc Nephrol
          <year>2010</year>
<volume>21</volume>
<issue>3</issue>
<fpage>478</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2009070698</pub-id>
<pub-id pub-id-type="pmid">20133480</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Doetsch</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Okenquist</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Lenz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boss</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic site containing DNAs</article-title>
<source/>Nucleic Acids Res
          <year>1991</year>
<volume>19</volume>
<issue>18</issue>
<fpage>4915</fpage>
<lpage>4920</lpage>
<pub-id pub-id-type="doi">10.1093/nar/19.18.4915</pub-id>
<pub-id pub-id-type="pmid">1923758</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sauter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schreiter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Roeyen</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gembardt</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hugo</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Isermann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Cold shock proteins mediate GN with Mesangioproliferation</article-title>
<source/>J Am Soc Nephrol
          <year>2016</year>
<volume>27</volume>
<issue>12</issue>
<fpage>3678</fpage>
<lpage>3689</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2015121367</pub-id>
<pub-id pub-id-type="pmid">27151923</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Padden</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Newburger</surname>
<given-names>PE</given-names>
</name>
</person-group>
<article-title>Nuclease sensitive element binding protein 1 gene disruption results in early embryonic lethality</article-title>
<source/>J Cell Biochem
          <year>2006</year>
<volume>99</volume>
<issue>1</issue>
<fpage>140</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.20911</pub-id>
<pub-id pub-id-type="pmid">16598782</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Books</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>Cold shock domain family members YB-1 and MSY4 share essential functions during murine embryogenesis</article-title>
<source/>Mol Cell Biol
          <year>2006</year>
<volume>26</volume>
<issue>22</issue>
<fpage>8410</fpage>
<lpage>8417</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.01196-06</pub-id>
<pub-id pub-id-type="pmid">16954378</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambros</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>A hierarchy of regulatory genes controls a larva-to-adult developmental switch in C. elegans</article-title>
<source/>Cell
          <year>1989</year>
<volume>57</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(89)90171-2</pub-id>
<pub-id pub-id-type="pmid">2702689</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vodyanik</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Smuga-Otto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Antosiewicz-Bourget</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frane</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jonsdottir</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Ruotti</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Slukvin</surname>
<given-names>II</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cell lines derived from human somatic cells</article-title>
<source/>Science
          <year>2007</year>
<volume>318</volume>
<issue>5858</issue>
<fpage>1917</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="doi">10.1126/science.1151526</pub-id>
<pub-id pub-id-type="pmid">18029452</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thornton</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>RI</given-names>
</name>
</person-group>
<article-title>How does Lin28 let-7 control development and disease?</article-title>
<source/>Trends Cell Biol
          <year>2012</year>
<volume>22</volume>
<issue>9</issue>
<fpage>474</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2012.06.001</pub-id>
<pub-id pub-id-type="pmid">22784697</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shyh-Chang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Segre</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Shinoda</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Einhorn</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Engreitz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hagan</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kharas</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Urbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Triboulet</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Consortium</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Investigators</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Lin28/let-7 axis regulates glucose metabolism</article-title>
<source/>Cell
          <year>2011</year>
<volume>147</volume>
<issue>1</issue>
<fpage>81</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.08.033</pub-id>
<pub-id pub-id-type="pmid">21962509</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rybak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Smirnova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pohl</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Nitsch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wulczyn</surname>
<given-names>FG</given-names>
</name>
</person-group>
<article-title>A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment</article-title>
<source/>Nat Cell Biol
          <year>2008</year>
<volume>10</volume>
<issue>8</issue>
<fpage>987</fpage>
<lpage>993</lpage>
<pub-id pub-id-type="doi">10.1038/ncb1759</pub-id>
<pub-id pub-id-type="pmid">18604195</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayr</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Mechanisms of Lin28-mediated miRNA and mRNA regulation--a structural and functional perspective</article-title>
<source/>Int J Mol Sci
          <year>2013</year>
<volume>14</volume>
<issue>8</issue>
<fpage>16532</fpage>
<lpage>16553</lpage>
<pub-id pub-id-type="doi">10.3390/ijms140816532</pub-id>
<pub-id pub-id-type="pmid">23939427</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groblewski</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bragado</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Leykam</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Purification and characterization of a novel physiological substrate for calcineurin in mammalian cells</article-title>
<source/>J Biol Chem
          <year>1998</year>
<volume>273</volume>
<issue>35</issue>
<fpage>22738</fpage>
<lpage>22744</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.35.22738</pub-id>
<pub-id pub-id-type="pmid">9712905</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schafer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Steffen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Krzykowski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Goke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Groblewski</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>CRHSP-24 phosphorylation is regulated by multiple signaling pathways in pancreatic acinar cells</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2003</year>
<volume>285</volume>
<issue>4</issue>
<fpage>G726</fpage>
<lpage>G734</lpage>
<pub-id pub-id-type="doi">10.1152/ajpgi.00111.2003</pub-id>
<pub-id pub-id-type="pmid">12801884</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeiffer</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>McAvoy</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Fecteau</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Deleault</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>CARHSP1 is required for effective tumor necrosis factor alpha mRNA stabilization and localizes to processing bodies and exosomes</article-title>
<source/>Mol Cell Biol
          <year>2011</year>
<volume>31</volume>
<issue>2</issue>
<fpage>277</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00775-10</pub-id>
<pub-id pub-id-type="pmid">21078874</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castiglia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Scaturro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nastasi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cestelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>PIPPin, a putative RNA-binding protein specifically expressed in the rat brain</article-title>
<source/>Biochem Biophys Res Commun
          <year>1996</year>
<volume>218</volume>
<issue>1</issue>
<fpage>390</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.1996.0068</pub-id>
<pub-id pub-id-type="pmid">8573167</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nastasi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Scaturro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bellafiore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raimondi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Beccari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cestelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>di Liegro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>PIPPin is a brain-specific protein that contains a cold-shock domain and binds specifically to H1 degrees and H3.3 mRNAs</article-title>
<source/>J Biol Chem
          <year>1999</year>
<volume>274</volume>
<issue>34</issue>
<fpage>24087</fpage>
<lpage>24093</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.34.24087</pub-id>
<pub-id pub-id-type="pmid">10446180</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nastasi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Muzi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Beccari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bellafiore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dolo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bologna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cestelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Specific neurons of brain cortex and cerebellum are PIPPin positive</article-title>
<source/>Neuroreport
          <year>2000</year>
<volume>11</volume>
<issue>10</issue>
<fpage>2233</fpage>
<lpage>2236</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200007140-00034</pub-id>
<pub-id pub-id-type="pmid">10923677</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raimondi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>D'Asaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Proia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nastasi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>RNA-binding ability of PIPPin requires the entire protein</article-title>
<source/>J Cell Mol Med
          <year>2003</year>
<volume>7</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1111/j.1582-4934.2003.tb00200.x</pub-id>
<pub-id pub-id-type="pmid">12767259</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bono</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Compagno</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Proia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Raimondi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schiera</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Favaloro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Campo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Donatelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Thyroid hormones induce sumoylation of the cold shock domain-containing protein PIPPin in developing rat brain and in cultured neurons</article-title>
<source/>Endocrinology
          <year>2007</year>
<volume>148</volume>
<issue>1</issue>
<fpage>252</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1210/en.2006-0660</pub-id>
<pub-id pub-id-type="pmid">17053029</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Liegro</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Schiera</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Proia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saladino</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Di Liegro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Identification in the rat brain of a set of nuclear proteins interacting with H1 degrees mRNA</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>229</volume>
<fpage>71</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.10.072</pub-id>
<pub-id pub-id-type="pmid">23159318</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Catnaigh</surname>
<given-names>PO</given-names>
</name>
</person-group>
<article-title>Regulation of the expression and activity of Unr in mammalian cells</article-title>
<source/>Biochem Soc Trans
          <year>2015</year>
<volume>43</volume>
<issue>6</issue>
<fpage>1241</fpage>
<lpage>1246</lpage>
<pub-id pub-id-type="doi">10.1042/BST20150165</pub-id>
<pub-id pub-id-type="pmid">26614667</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Catnaigh</surname>
<given-names>PO</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>Post-transcriptional regulation of gene expression by Unr</article-title>
<source/>Biochem Soc Trans
          <year>2015</year>
<volume>43</volume>
<issue>3</issue>
<fpage>323</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1042/BST20140271</pub-id>
<pub-id pub-id-type="pmid">26009170</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeffers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Paciucci</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pellicer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Characterization of unr; a gene closely linked to N-ras</article-title>
<source/>Nucleic Acids Res
          <year>1990</year>
<volume>18</volume>
<issue>16</issue>
<fpage>4891</fpage>
<lpage>4899</lpage>
<pub-id pub-id-type="pmid">2204029</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeffers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pellicer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Multiple intragenic elements regulate the expression of the murine N-ras gene</article-title>
<source/>Oncogene
          <year>1992</year>
<volume>7</volume>
<issue>11</issue>
<fpage>2115</fpage>
<lpage>2123</lpage>
<pub-id pub-id-type="pmid">1437142</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dautry</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Organization of the unr/N-ras locus: characterization of the promoter region of the human unr gene</article-title>
<source/>Nucleic Acids Res
          <year>1992</year>
<volume>20</volume>
<issue>23</issue>
<fpage>6355</fpage>
<lpage>6361</lpage>
<pub-id pub-id-type="doi">10.1093/nar/20.23.6355</pub-id>
<pub-id pub-id-type="pmid">1475196</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boussadia</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Amiot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cases</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Triqueneaux</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dautry</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Transcription of unr (upstream of N-ras) down-modulates N-ras expression in vivo</article-title>
<source/>FEBS Lett
          <year>1997</year>
<volume>420</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-5793(97)01479-8</pub-id>
<pub-id pub-id-type="pmid">9450542</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Triqueneaux</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Deschamps</surname>
<given-names>S</given-names>
</name>
<name>
<surname>le Maire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doniger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dautry</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Nucleic acid binding and intracellular localization of unr, a protein with five cold shock domains</article-title>
<source/>Nucleic Acids Res
          <year>1994</year>
<volume>22</volume>
<issue>13</issue>
<fpage>2643</fpage>
<lpage>2650</lpage>
<pub-id pub-id-type="doi">10.1093/nar/22.13.2643</pub-id>
<pub-id pub-id-type="pmid">7518919</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doniger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Landsman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gonda</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wistow</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The product of unr, the highly conserved gene upstream of N-ras, contains multiple repeats similar to the cold-shock domain (CSD), a putative DNA-binding motif</article-title>
<source/>New Biol
          <year>1992</year>
<volume>4</volume>
<issue>4</issue>
<fpage>389</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="pmid">1622933</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boussadia</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dautry</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Exon skipping in the expression of the gene immediately upstream of N-ras (unr/NRU)</article-title>
<source/>Biochim Biophys Acta
          <year>1993</year>
<volume>1172</volume>
<issue>1–2</issue>
<fpage>64</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/0167-4781(93)90270-N</pub-id>
<pub-id pub-id-type="pmid">8439573</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Garcia-Espana</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jeffers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pellicer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The unr gene: evolutionary considerations and nucleic acid-binding properties of its long isoform product</article-title>
<source/>DNA Cell Biol
          <year>1999</year>
<volume>18</volume>
<issue>3</issue>
<fpage>209</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1089/104454999315420</pub-id>
<pub-id pub-id-type="pmid">10098602</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Triqueneaux</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Velten</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Franzon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dautry</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>RNA binding specificity of Unr, a protein with five cold shock domains</article-title>
<source/>Nucleic Acids Res
          <year>1999</year>
<volume>27</volume>
<issue>8</issue>
<fpage>1926</fpage>
<lpage>1934</lpage>
<pub-id pub-id-type="doi">10.1093/nar/27.8.1926</pub-id>
<pub-id pub-id-type="pmid">10101203</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Coldwell</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras</article-title>
<source/>Mol Cell Biol
          <year>2001</year>
<volume>21</volume>
<issue>10</issue>
<fpage>3364</fpage>
<lpage>3374</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.21.10.3364-3374.2001</pub-id>
<pub-id pub-id-type="pmid">11313462</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawicka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bushell</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Spriggs</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein</article-title>
<source/>Biochem Soc Trans
          <year>2008</year>
<volume>36</volume>
<issue>Pt 4</issue>
<fpage>641</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1042/BST0360641</pub-id>
<pub-id pub-id-type="pmid">18631133</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elatmani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dormoy-Raclet</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dubus</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dautry</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chazaud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The RNA-binding protein Unr prevents mouse embryonic stem cells differentiation toward the primitive endoderm lineage</article-title>
<source/>Stem Cells
          <year>2011</year>
<volume>29</volume>
<issue>10</issue>
<fpage>1504</fpage>
<lpage>1516</lpage>
<pub-id pub-id-type="doi">10.1002/stem.712</pub-id>
<pub-id pub-id-type="pmid">21954113</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bartsch</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guerrero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahuja</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schindler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Moresco</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>JR</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Gebauer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bazzi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dieterich</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kurian</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vilchez</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A post-transcriptional program coordinated by CSDE1 prevents intrinsic neural differentiation of human embryonic stem cells</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<issue>1</issue>
<fpage>1456</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-01744-5</pub-id>
<pub-id pub-id-type="pmid">29129916</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markmiller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soltanieh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Server</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Krach</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fulzele</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Kankel</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>EJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Context-dependent and disease-specific diversity in protein interactions within stress granules</article-title>
<source/>Cell
          <year>2018</year>
<volume>172</volume>
<issue>3</issue>
<fpage>590</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2017.12.032</pub-id>
<pub-id pub-id-type="pmid">29373831</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youn</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Dunham</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>JDR</given-names>
</name>
<name>
<surname>Bashkurov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Bagci</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rathod</surname>
<given-names>B</given-names>
</name>
<name>
<surname>MacLeod</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>SWM</given-names>
</name>
<name>
<surname>Angers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Fabian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cote</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Gingras</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>High-density proximity mapping reveals the subcellular organization of mRNA-associated granules and bodies</article-title>
<source/>Mol Cell
          <year>2018</year>
<volume>69</volume>
<issue>3</issue>
<fpage>517</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2017.12.020</pub-id>
<pub-id pub-id-type="pmid">29395067</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bartlam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Structure-functional analyses of CRHSP-24 plasticity and dynamics in oxidative stress response</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<issue>11</issue>
<fpage>9623</fpage>
<lpage>9635</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.177436</pub-id>
<pub-id pub-id-type="pmid">21177848</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahboubi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stochaj</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Cytoplasmic stress granules: dynamic modulators of cell signaling and disease</article-title>
<source/>Biochim Biophys Acta
          <year>2017</year>
<volume>1863</volume>
<issue>4</issue>
<fpage>884</fpage>
<lpage>895</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2016.12.022</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulow</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bienert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>IG</given-names>
</name>
</person-group>
<article-title>BiP is feed-back regulated by control of protein translation efficiency</article-title>
<source/>J Cell Sci
          <year>2002</year>
<volume>115</volume>
<issue>Pt 11</issue>
<fpage>2443</fpage>
<lpage>2452</lpage>
<pub-id pub-id-type="pmid">12006628</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Ra</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Differential control of interleukin-6 mRNA levels by cellular distribution of YB-1</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>11</issue>
<fpage>e112754</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0112754</pub-id>
<pub-id pub-id-type="pmid">25398005</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kossinova</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Gopanenko</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Tamkovich</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Krasheninina</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Tupikin</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Kiseleva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yanshina</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Malygin</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ven'yaminova</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Kabilov</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Karpova</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>Cytosolic YB-1 and NSUN2 are the only proteins recognizing specific motifs present in mRNAs enriched in exosomes</article-title>
<source/>Biochim Biophys Acta
          <year>2017</year>
<volume>1865</volume>
<issue>6</issue>
<fpage>664</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbapap.2017.03.010</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castellana</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Aasen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moreno-Bueno</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Ramon y Cajal</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<issue>35</issue>
<fpage>38239</fpage>
<lpage>38256</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.5664</pub-id>
<pub-id pub-id-type="pmid">26512918</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boor</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling</article-title>
<source/>Nephron Exp Nephrol
          <year>2011</year>
<volume>118</volume>
<issue>4</issue>
<fpage>e100</fpage>
<lpage>e108</lpage>
<pub-id pub-id-type="doi">10.1159/000324209</pub-id>
<pub-id pub-id-type="pmid">21372592</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tonks</surname>
<given-names>NK</given-names>
</name>
</person-group>
<article-title>Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling</article-title>
<source/>EMBO J
          <year>2003</year>
<volume>22</volume>
<issue>3</issue>
<fpage>479</fpage>
<lpage>493</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/cdg067</pub-id>
<pub-id pub-id-type="pmid">12554649</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorokin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Selyutina</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Skabkin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Guryanov</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Nazimov</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Th'ng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Evdokimova</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response</article-title>
<source/>EMBO J
          <year>2005</year>
<volume>24</volume>
<issue>20</issue>
<fpage>3602</fpage>
<lpage>3612</lpage>
<pub-id pub-id-type="doi">10.1038/sj.emboj.7600830</pub-id>
<pub-id pub-id-type="pmid">16193061</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blenkiron</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Print</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Lasham</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>11</issue>
<fpage>e80171</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0080171</pub-id>
<pub-id pub-id-type="pmid">24260353</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shahzad</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Al-Dabet</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ranjan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wolter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kohli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dhople</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Esmon</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Grone</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grone</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Madhusudhan</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activated protein C ameliorates renal ischemia-reperfusion injury by restricting Y-box binding Protein-1 ubiquitination</article-title>
<source/>J Am Soc Nephrol
          <year>2015</year>
<volume>26</volume>
<issue>11</issue>
<fpage>2789</fpage>
<lpage>2799</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2014080846</pub-id>
<pub-id pub-id-type="pmid">26015455</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kedersha</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Stoecklin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ayodele</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yacono</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lykke-Andersen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fritzler</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Scheuner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Golan</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Stress granules and processing bodies are dynamically linked sites of mRNP remodeling</article-title>
<source/>J Cell Biol
          <year>2005</year>
<volume>169</volume>
<issue>6</issue>
<fpage>871</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200502088</pub-id>
<pub-id pub-id-type="pmid">15967811</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sheth</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Valencia-Sanchez</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brengues</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Processing bodies require RNA for assembly and contain nontranslating mRNAs</article-title>
<source/>RNA
          <year>2005</year>
<volume>11</volume>
<issue>4</issue>
<fpage>371</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1261/rna.7258505</pub-id>
<pub-id pub-id-type="pmid">15703442</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tourriere</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chebli</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zekri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Courselaud</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bertrand</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tazi</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The RasGAP-associated endoribonuclease G3BP assembles stress granules</article-title>
<source/>J Cell Biol
          <year>2003</year>
<volume>160</volume>
<issue>6</issue>
<fpage>823</fpage>
<lpage>831</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200212128</pub-id>
<pub-id pub-id-type="pmid">12642610</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kedersha</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Stress granules, P-bodies and cancer</article-title>
<source/>Biochim Biophys Acta
          <year>2015</year>
<volume>1849</volume>
<issue>7</issue>
<fpage>861</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.11.009</pub-id>
<pub-id pub-id-type="pmid">25482014</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Treeck</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Protter</surname>
<given-names>DSW</given-names>
</name>
<name>
<surname>Matheny</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Khong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Link</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>RNA self-assembly contributes to stress granule formation and defining the stress granule transcriptome</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2018</year>
<volume>115</volume>
<issue>11</issue>
<fpage>2734</fpage>
<lpage>2739</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1800038115</pub-id>
<pub-id pub-id-type="pmid">29483269</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Protter</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Principles and properties of stress granules</article-title>
<source/>Trends Cell Biol
          <year>2016</year>
<volume>26</volume>
<issue>9</issue>
<fpage>668</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2016.05.004</pub-id>
<pub-id pub-id-type="pmid">27289443</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bounedjah</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Desforges</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Pioche-Durieu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marco</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Curmi</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Guerquin-Kern</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Pietrement</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Pastre</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Free mRNA in excess upon polysome dissociation is a scaffold for protein multimerization to form stress granules</article-title>
<source/>Nucleic Acids Res
          <year>2014</year>
<volume>42</volume>
<issue>13</issue>
<fpage>8678</fpage>
<lpage>8691</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gku582</pub-id>
<pub-id pub-id-type="pmid">25013173</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maharana</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pozniakovsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Poser</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bickle</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rizk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guillen-Boixet</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Franzmann</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Jahnel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marrone</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Sterneckert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tomancak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>AA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RNA buffers the phase separation behavior of prion-like RNA binding proteins</article-title>
<source/>Science
          <year>2018</year>
<volume>360</volume>
<issue>6391</issue>
<fpage>918</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1126/science.aar7366</pub-id>
<pub-id pub-id-type="pmid">29650702</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Mirzaei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Goldsmith</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Longgood</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grishin</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Frantz</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sawaya</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels</article-title>
<source/>Cell
          <year>2012</year>
<volume>149</volume>
<issue>4</issue>
<fpage>753</fpage>
<lpage>767</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.04.017</pub-id>
<pub-id pub-id-type="pmid">22579281</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Mirzaei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>McKnight</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies</article-title>
<source/>Cell
          <year>2012</year>
<volume>149</volume>
<issue>4</issue>
<fpage>768</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.04.016</pub-id>
<pub-id pub-id-type="pmid">22579282</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagier-Tourenne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Polymenidou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration</article-title>
<source/>Hum Mol Genet
          <year>2010</year>
<volume>19</volume>
<issue>R1</issue>
<fpage>R46</fpage>
<lpage>R64</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq137</pub-id>
<pub-id pub-id-type="pmid">20400460</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>Daisuke</given-names>
</name>
<name>
<surname>Hatano</surname>
<given-names>Mami</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Norihiro</given-names>
</name>
</person-group>
<article-title>RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration</article-title>
<source/>Science Translational Medicine
          <year>2017</year>
<volume>9</volume>
<issue>415</issue>
<fpage>eaah5436</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aah5436</pub-id>
<pub-id pub-id-type="pmid">29118263</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maziuk</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ballance</surname>
<given-names>HI</given-names>
</name>
<name>
<surname>Wolozin</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Dysregulation of RNA binding protein aggregation in neurodegenerative disorders</article-title>
<source/>Front Mol Neurosci
          <year>2017</year>
<volume>10</volume>
<fpage>89</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00089</pub-id>
<pub-id pub-id-type="pmid">28420962</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchan</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kolaitis</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function</article-title>
<source/>Cell
          <year>2013</year>
<volume>153</volume>
<issue>7</issue>
<fpage>1461</fpage>
<lpage>1474</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.05.037</pub-id>
<pub-id pub-id-type="pmid">23791177</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Staats</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Hendricks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Linares</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kisler</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Menendez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Woolwine</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons</article-title>
<source/>Nat Med
          <year>2018</year>
<volume>24</volume>
<issue>3</issue>
<fpage>313</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4490</pub-id>
<pub-id pub-id-type="pmid">29400714</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>P</given-names>
</name>
<name>
<surname>O'Day</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Emara</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2014</year>
<volume>111</volume>
<issue>51</issue>
<fpage>18201</fpage>
<lpage>18206</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1407361111</pub-id>
<pub-id pub-id-type="pmid">25404306</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kedersha</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mammalian stress granules and processing bodies</article-title>
<source/>Methods Enzymol
          <year>2007</year>
<volume>431</volume>
<fpage>61</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/S0076-6879(07)31005-7</pub-id>
<pub-id pub-id-type="pmid">17923231</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guryanov</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Filimonov</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Timchenko</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Melnik</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Kihara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kutyshenko</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Semisotnov</surname>
<given-names>GV</given-names>
</name>
</person-group>
<article-title>The major mRNP protein YB-1: structural and association properties in solution</article-title>
<source/>Biochim Biophys Acta
          <year>2013</year>
<volume>1834</volume>
<issue>2</issue>
<fpage>559</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbapap.2012.11.007</pub-id>
<pub-id pub-id-type="pmid">23220387</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selivanova</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Guryanov</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Enin</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Skabkin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Serdyuk</surname>
<given-names>IN</given-names>
</name>
</person-group>
<article-title>YB-1 is capable of forming extended nanofibrils</article-title>
<source/>Biochemistry (Mosc)
          <year>2010</year>
<volume>75</volume>
<issue>1</issue>
<fpage>115</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1134/S0006297910010153</pub-id>
<pub-id pub-id-type="pmid">20331432</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guryanov</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Selivanova</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Nikulin</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Enin</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Melnik</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Kretov</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Serdyuk</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
</person-group>
<article-title>Formation of amyloid-like fibrils by Y-box binding protein 1 (YB-1) is mediated by its cold shock domain and modulated by disordered terminal domains</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>5</issue>
<fpage>e36969</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0036969</pub-id>
<pub-id pub-id-type="pmid">22590640</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kretov</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Curmi</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Abrakhi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Desforges</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Pastre</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>mRNA and DNA selection via protein multimerization: YB-1 as a case study</article-title>
<source/>Nucleic Acids Res
          <year>2015</year>
<volume>43</volume>
<issue>19</issue>
<fpage>9457</fpage>
<lpage>9473</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv822</pub-id>
<pub-id pub-id-type="pmid">26271991</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skabkin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kiselyova</surname>
<given-names>OI</given-names>
</name>
<name>
<surname>Chernov</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Sorokin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Dubrovin</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Yaminsky</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Vasiliev</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
</person-group>
<article-title>Structural organization of mRNA complexes with major core mRNP protein YB-1</article-title>
<source/>Nucleic Acids Res
          <year>2004</year>
<volume>32</volume>
<issue>18</issue>
<fpage>5621</fpage>
<lpage>5635</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkh889</pub-id>
<pub-id pub-id-type="pmid">15494450</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kloks</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Spronk</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lasonder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vuister</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Grzesiek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hilbers</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1</article-title>
<source/>J Mol Biol
          <year>2002</year>
<volume>316</volume>
<issue>2</issue>
<fpage>317</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1006/jmbi.2001.5334</pub-id>
<pub-id pub-id-type="pmid">11851341</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrakhi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kretov</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Desforges</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dobra</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bouhss</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pastre</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Nanoscale analysis reveals the maturation of neurodegeneration-associated protein aggregates: grown in mRNA granules then released by stress granule proteins</article-title>
<source/>ACS Nano
          <year>2017</year>
<volume>11</volume>
<issue>7</issue>
<fpage>7189</fpage>
<lpage>7200</lpage>
<pub-id pub-id-type="doi">10.1021/acsnano.7b03071</pub-id>
<pub-id pub-id-type="pmid">28657719</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somasekharan</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>El-Naggar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leprivier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hajee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grunewald</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Delattre</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Evdokimova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gleave</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1</article-title>
<source/>J Cell Biol
          <year>2015</year>
<volume>208</volume>
<issue>7</issue>
<fpage>913</fpage>
<lpage>929</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201411047</pub-id>
<pub-id pub-id-type="pmid">25800057</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cherkasova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bankhead</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bukau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stoecklin</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Translation suppression promotes stress granule formation and cell survival in response to cold shock</article-title>
<source/>Mol Biol Cell
          <year>2012</year>
<volume>23</volume>
<issue>19</issue>
<fpage>3786</fpage>
<lpage>3800</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.e12-04-0296</pub-id>
<pub-id pub-id-type="pmid">22875991</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Hypo- and hyper-assembly diseases of RNA-protein complexes</article-title>
<source/>Trends Mol Med
          <year>2016</year>
<volume>22</volume>
<issue>7</issue>
<fpage>615</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2016.05.005</pub-id>
<pub-id pub-id-type="pmid">27263464</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deretic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dupont</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation</article-title>
<source/>Trends Cell Biol
          <year>2012</year>
<volume>22</volume>
<issue>8</issue>
<fpage>397</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2012.04.008</pub-id>
<pub-id pub-id-type="pmid">22677446</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabouille</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Pathways of unconventional protein secretion</article-title>
<source/>Trends Cell Biol
          <year>2017</year>
<volume>27</volume>
<issue>3</issue>
<fpage>230</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2016.11.007</pub-id>
<pub-id pub-id-type="pmid">27989656</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Halfter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Muehlenberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Knott</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Dooley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bernhagen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen</article-title>
<source/>EMBO Rep
          <year>2009</year>
<volume>10</volume>
<issue>7</issue>
<fpage>783</fpage>
<lpage>789</lpage>
<pub-id pub-id-type="doi">10.1038/embor.2009.81</pub-id>
<pub-id pub-id-type="pmid">19483673</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Muhlenberg</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Eitner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lendahl</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Bernhagen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dooley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation</article-title>
<source/>J Biol Chem
          <year>2009</year>
<volume>284</volume>
<issue>39</issue>
<fpage>26928</fpage>
<lpage>26940</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.046599</pub-id>
<pub-id pub-id-type="pmid">19640841</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palicharla</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Maddika</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>HACE1 mediated K27 ubiquitin linkage leads to YB-1 protein secretion</article-title>
<source/>Cell Signal
          <year>2015</year>
<volume>27</volume>
<issue>12</issue>
<fpage>2355</fpage>
<lpage>2362</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2015.09.001</pub-id>
<pub-id pub-id-type="pmid">26343856</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colombo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moita</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van Niel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kowal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vigneron</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Benaroch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Manel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Moita</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Thery</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Raposo</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles</article-title>
<source/>J Cell Sci
          <year>2013</year>
<volume>126</volume>
<issue>Pt 24</issue>
<fpage>5553</fpage>
<lpage>5565</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.128868</pub-id>
<pub-id pub-id-type="pmid">24105262</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<mixed-citation publication-type="other">Shurtleff MJ, Temoche-Diaz MM, Karfilis KV, Ri S, Schekman R. Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction. elife. 2016;5. 10.7554/eLife.19276.</mixed-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suresh</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Tsutsumi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling</article-title>
<source/>Eur J Cell Biol
          <year>2018</year>
<volume>97</volume>
<issue>3</issue>
<fpage>163</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2018.02.003</pub-id>
<pub-id pub-id-type="pmid">29478751</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanshina</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Kossinova</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Gopanenko</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Krasheninina</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Malygin</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Venyaminova</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Karpova</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>Structural features of the interaction of the 3′-untranslated region of mRNA containing exosomal RNA-specific motifs with YB-1, a potential mediator of mRNA sorting</article-title>
<source/>Biochimie
          <year>2018</year>
<volume>144</volume>
<fpage>134</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.biochi.2017.11.007</pub-id>
<pub-id pub-id-type="pmid">29133115</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keerthikumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chisanga</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ariyaratne</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Al Saffar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pathan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jois</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chilamkurti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gangoda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mathivanan</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>ExoCarta: a web-based compendium of Exosomal cargo</article-title>
<source/>J Mol Biol
          <year>2016</year>
<volume>428</volume>
<issue>4</issue>
<fpage>688</fpage>
<lpage>692</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmb.2015.09.019</pub-id>
<pub-id pub-id-type="pmid">26434508</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>Richard J.</given-names>
</name>
<name>
<surname>Kalra</surname>
<given-names>Hina</given-names>
</name>
<name>
<surname>Mathivanan</surname>
<given-names>Suresh</given-names>
</name>
</person-group>
<article-title>ExoCarta as a resource for exosomal research</article-title>
<source/>Journal of Extracellular Vesicles
          <year>2012</year>
<volume>1</volume>
<issue>1</issue>
<fpage>18374</fpage>
<pub-id pub-id-type="doi">10.3402/jev.v1i0.18374</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Royer-Pokora</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fietze</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jurchott</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hildebrandt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Trost</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Leenders</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Claude</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Theuring</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bargou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dietel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Royer</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification</article-title>
<source/>Cancer Res
          <year>2005</year>
<volume>65</volume>
<issue>10</issue>
<fpage>4078</fpage>
<lpage>4087</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-4056</pub-id>
<pub-id pub-id-type="pmid">15899797</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosnopfel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sinnberg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Schittek</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Y-box binding protein 1--a prognostic marker and target in tumour therapy</article-title>
<source/>Eur J Cell Biol
          <year>2014</year>
<volume>93</volume>
<issue>1–2</issue>
<fpage>61</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2013.11.007</pub-id>
<pub-id pub-id-type="pmid">24461929</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asakuno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uchiumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Isono</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D</article-title>
<source/>Biochem Biophys Res Commun
          <year>1994</year>
<volume>199</volume>
<issue>3</issue>
<fpage>1428</fpage>
<lpage>1435</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.1994.1390</pub-id>
<pub-id pub-id-type="pmid">7908518</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bargou</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Jurchott</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wagener</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Metzner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bommert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mapara</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Winzer</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Dietel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dorken</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Royer</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression</article-title>
<source/>Nat Med
          <year>1997</year>
<volume>3</volume>
<issue>4</issue>
<fpage>447</fpage>
<lpage>450</lpage>
<pub-id pub-id-type="doi">10.1038/nm0497-447</pub-id>
<pub-id pub-id-type="pmid">9095180</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maiti</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Boldogh</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hazra</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhakat</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1</article-title>
<source/>Mol Cell Biol
          <year>2008</year>
<volume>28</volume>
<issue>23</issue>
<fpage>7066</fpage>
<lpage>7080</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00244-08</pub-id>
<pub-id pub-id-type="pmid">18809583</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Uchiumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Toi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamana</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsuneyoshi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yasumoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>The role of nuclear Y-box binding protein 1 as a global marker in drug resistance</article-title>
<source/>Mol Cancer Ther
          <year>2004</year>
<volume>3</volume>
<issue>11</issue>
<fpage>1485</fpage>
<lpage>1492</lpage>
<pub-id pub-id-type="pmid">15542787</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harbeck</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dettmar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jurchott</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Royer</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1</article-title>
<source/>Int J Cancer
          <year>2002</year>
<volume>97</volume>
<issue>3</issue>
<fpage>278</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.1610</pub-id>
<pub-id pub-id-type="pmid">11774277</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ohishi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hinoshita</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Uchiumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kinukawa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsuneyoshi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma</article-title>
<source/>J Pathol
          <year>2003</year>
<volume>199</volume>
<issue>2</issue>
<fpage>251</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1002/path.1282</pub-id>
<pub-id pub-id-type="pmid">12533839</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yong</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma</article-title>
<source/>Exp Hematol
          <year>2011</year>
<volume>39</volume>
<issue>5</issue>
<fpage>558</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1016/j.exphem.2011.01.013</pub-id>
<pub-id pub-id-type="pmid">21300134</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Setoguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hachisuka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Obchoei</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shinkai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hyodo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Harada-Shiba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Obika</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Antisense oligonucleotides targeting Y-box binding Protein-1 inhibit tumor angiogenesis by downregulating Bcl-xL-VEGFR2/-tie axes</article-title>
<source/>Mol Ther Nucleic Acids
          <year>2017</year>
<volume>9</volume>
<fpage>170</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1016/j.omtn.2017.09.004</pub-id>
<pub-id pub-id-type="pmid">29246296</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>di Martino</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Troiano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guarino</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pollice</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vivo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>La Mantia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Calabro</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>DeltaNp63alpha controls YB-1 protein stability: evidence on YB-1 as a new player in keratinocyte differentiation</article-title>
<source/>Genes Cells
          <year>2016</year>
<volume>21</volume>
<issue>6</issue>
<fpage>648</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.1111/gtc.12373</pub-id>
<pub-id pub-id-type="pmid">27168020</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chibi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Skepu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>DJ</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Moolman-Smook</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Pugh</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1</article-title>
<source/>J Mol Biol
          <year>2008</year>
<volume>384</volume>
<issue>4</issue>
<fpage>908</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmb.2008.09.060</pub-id>
<pub-id pub-id-type="pmid">18851979</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Roeyen</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Scurt</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kuhl</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Martinkus</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Royer</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Stefanidis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Dooley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities</article-title>
<source/>Cell Commun Signal
          <year>2013</year>
<volume>11</volume>
<fpage>63</fpage>
<pub-id pub-id-type="doi">10.1186/1478-811X-11-63</pub-id>
<pub-id pub-id-type="pmid">24103640</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Selyutina</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Buldakov</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Evdokimova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Sorokin</surname>
<given-names>AV</given-names>
</name>
</person-group>
<article-title>The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress</article-title>
<source/>Cell Cycle
          <year>2013</year>
<volume>12</volume>
<issue>24</issue>
<fpage>3791</fpage>
<lpage>3803</lpage>
<pub-id pub-id-type="doi">10.4161/cc.26670</pub-id>
<pub-id pub-id-type="pmid">24107631</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stenina</surname>
<given-names>OI</given-names>
</name>
<name>
<surname>Poptic</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Di Corleto</surname>
<given-names>PE</given-names>
</name>
</person-group>
<article-title>Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells</article-title>
<source/>J Clin Invest
          <year>2000</year>
<volume>106</volume>
<issue>4</issue>
<fpage>579</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="doi">10.1172/JCI9075</pub-id>
<pub-id pub-id-type="pmid">10953033</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tacke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kanig</surname>
<given-names>N</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaehne</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Eberhardt</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Shpacovitch</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Trautwein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease</article-title>
<source/>BMC Cancer
          <year>2011</year>
<volume>11</volume>
<fpage>185</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2407-11-185</pub-id>
<pub-id pub-id-type="pmid">21595987</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tacke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Galm</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kanig</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yagmur</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Eberhardt</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin</article-title>
<source/>BMC Cancer
          <year>2014</year>
<volume>14</volume>
<fpage>33</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2407-14-33</pub-id>
<pub-id pub-id-type="pmid">24443788</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rohr</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Braicu</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chekerov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dechend</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Heidecke</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dragun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gorny</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sehouli</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: a study by the tumor Bank ovarian Cancer (TOC)</article-title>
<source/>Cytokine
          <year>2016</year>
<volume>85</volume>
<fpage>157</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2016.06.021</pub-id>
<pub-id pub-id-type="pmid">27371774</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Bettencourt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alho</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Mansinho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abreu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pulido</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Macedo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vendrell</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pacheco</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Casimiro</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases</article-title>
<source/>J Bone Oncol
          <year>2017</year>
<volume>6</volume>
<fpage>16</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbo.2017.01.002</pub-id>
<pub-id pub-id-type="pmid">28194325</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>RNA-binding protein Lin28 in cancer and immunity</article-title>
<source/>Cancer Lett
          <year>2016</year>
<volume>375</volume>
<issue>1</issue>
<fpage>108</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1016/j.canlet.2016.02.050</pub-id>
<pub-id pub-id-type="pmid">26945970</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Spriggs</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Ostrowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bomsztyk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ostarek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo</article-title>
<source/>Oncogene
          <year>2003</year>
<volume>22</volume>
<issue>39</issue>
<fpage>8012</fpage>
<lpage>8020</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1206645</pub-id>
<pub-id pub-id-type="pmid">12970749</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grosset</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jacquemin-Sablon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shyu</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>A mechanism for translationally coupled mRNA turnover: interaction between the poly(a) tail and a c-fos RNA coding determinant via a protein complex</article-title>
<source/>Cell
          <year>2000</year>
<volume>103</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)00102-1</pub-id>
<pub-id pub-id-type="pmid">11051545</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wurth</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Papasaikas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Olmeda</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bley</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Calvo</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Guerrero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cerezo-Wallis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Martinez-Useros</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garcia-Fernandez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huttelmaier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Soengas</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Gebauer</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>UNR/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis</article-title>
<source/>Cancer Cell
          <year>2016</year>
<volume>30</volume>
<issue>5</issue>
<fpage>694</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccell.2016.10.004</pub-id>
<pub-id pub-id-type="pmid">27908735</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Parry</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Hepsin and prostate cancer</article-title>
<source/>Front Biosci
          <year>2007</year>
<volume>12</volume>
<fpage>5052</fpage>
<lpage>5059</lpage>
<pub-id pub-id-type="doi">10.2741/2447</pub-id>
<pub-id pub-id-type="pmid">17569629</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2alpha phosphorylation in prostate cancer</article-title>
<source/>Cell Signal
          <year>2015</year>
<volume>27</volume>
<issue>4</issue>
<fpage>789</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2014.12.020</pub-id>
<pub-id pub-id-type="pmid">25576733</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Useros</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Georgiev-Hristov</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fernandez-Acenero</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Borrero-Palacios</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Indacochea</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guerrero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cebrian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gomez Del Pulgar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Puime-Otin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Del Puerto-Nevado</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rodriguez-Remirez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Celdran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gebauer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Garcia-Foncillas</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: a proof-of-concept</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<issue>8</issue>
<fpage>e0182044</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0182044</pub-id>
<pub-id pub-id-type="pmid">28763470</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanssen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Alidousty</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boor</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>van Roeyen</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Tacke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Heymann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tittel</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo</article-title>
<source/>J Immunol
          <year>2013</year>
<volume>191</volume>
<issue>5</issue>
<fpage>2604</fpage>
<lpage>2613</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1300416</pub-id>
<pub-id pub-id-type="pmid">23872051</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gibbert</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alidousty</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kunter</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Rembiak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Enders</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jankowski</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis</article-title>
<source/>Kidney Int
          <year>2016</year>
<volume>90</volume>
<issue>6</issue>
<fpage>1226</fpage>
<lpage>1237</lpage>
<pub-id pub-id-type="doi">10.1016/j.kint.2016.07.008</pub-id>
<pub-id pub-id-type="pmid">27591085</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alidousty</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Alampour-Rajabi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Bernhagen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Calcineurin-mediated YB-1 dephosphorylation regulates CCL5 expression during monocyte differentiation</article-title>
<source/>J Biol Chem
          <year>2014</year>
<volume>289</volume>
<issue>31</issue>
<fpage>21401</fpage>
<lpage>21412</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.562991</pub-id>
<pub-id pub-id-type="pmid">24947514</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kretzler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tacke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zimmermann</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stefanidis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1</article-title>
<source/>Kidney Int
          <year>2009</year>
<volume>75</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1038/ki.2008.457</pub-id>
<pub-id pub-id-type="pmid">18800033</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krohn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Bot</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Zernecke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shagdarsuren</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Liehn</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>van Santbrink</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Biessen</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice</article-title>
<source/>Circulation
          <year>2007</year>
<volume>116</volume>
<issue>16</issue>
<fpage>1812</fpage>
<lpage>1820</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.708016</pub-id>
<pub-id pub-id-type="pmid">17893273</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhawan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pytlak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kulshrestha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blaxall</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Taubman</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells</article-title>
<source/>Mol Cell Biol
          <year>2012</year>
<volume>32</volume>
<issue>18</issue>
<fpage>3768</fpage>
<lpage>3775</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00846-12</pub-id>
<pub-id pub-id-type="pmid">22801372</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Gherzi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Gaietta</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jurchott</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Royer</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation</article-title>
<source/>Genes Dev
          <year>2000</year>
<volume>14</volume>
<issue>10</issue>
<fpage>1236</fpage>
<lpage>1248</lpage>
<pub-id pub-id-type="pmid">10817758</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coles</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lambrusco</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vadas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Goodall</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts</article-title>
<source/>Nucleic Acids Res
          <year>2002</year>
<volume>30</volume>
<issue>22</issue>
<fpage>4845</fpage>
<lpage>4854</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkf615</pub-id>
<pub-id pub-id-type="pmid">12433987</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Vadas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cells</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<issue>11</issue>
<fpage>7943</fpage>
<lpage>7951</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M009836200</pub-id>
<pub-id pub-id-type="pmid">11116154</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraser</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>van Roeyen</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Muehlenberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells</article-title>
<source/>Kidney Int
          <year>2008</year>
<volume>73</volume>
<issue>6</issue>
<fpage>724</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ki.5002719</pub-id>
<pub-id pub-id-type="pmid">18075498</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berquin</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dziubinski</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Nolan</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Ethier</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells</article-title>
<source/>Oncogene
          <year>2005</year>
<volume>24</volume>
<issue>19</issue>
<fpage>3177</fpage>
<lpage>3186</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1208504</pub-id>
<pub-id pub-id-type="pmid">15735691</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hosoi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fotovati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Oie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shimoyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nishio</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells</article-title>
<source/>Oncogene
          <year>2007</year>
<volume>26</volume>
<issue>19</issue>
<fpage>2736</fpage>
<lpage>2746</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1210084</pub-id>
<pub-id pub-id-type="pmid">17072343</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Harendza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pollock</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Lovett</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1</article-title>
<source/>J Biol Chem
          <year>1997</year>
<volume>272</volume>
<issue>36</issue>
<fpage>22905</fpage>
<lpage>22912</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.36.22905</pub-id>
<pub-id pub-id-type="pmid">9278454</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanssen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Alidousty</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Djudjaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boor</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney</article-title>
<source/>J Immunol
          <year>2011</year>
<volume>187</volume>
<issue>1</issue>
<fpage>298</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1100382</pub-id>
<pub-id pub-id-type="pmid">21606250</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mitsui</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mauviel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakatsuka</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Y-box-binding protein YB-1 mediates transcriptional repression of human alpha 2(I) collagen gene expression by interferon-gamma</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<issue>7</issue>
<fpage>5156</fpage>
<lpage>5162</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M208724200</pub-id>
<pub-id pub-id-type="pmid">12446674</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Roeyen</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Eitner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Martinkus</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thieltges</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Ostendorf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bokemeyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Luscher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Luscher-Firzlaff</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease</article-title>
<source/>J Am Soc Nephrol
          <year>2005</year>
<volume>16</volume>
<issue>10</issue>
<fpage>2985</fpage>
<lpage>2996</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2004111009</pub-id>
<pub-id pub-id-type="pmid">16093451</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raffetseder</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Liehn</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Role of cold shock Y-box protein-1 in inflammation, atherosclerosis and organ transplant rejection</article-title>
<source/>Eur J Cell Biol
          <year>2012</year>
<volume>91</volume>
<issue>6–7</issue>
<fpage>567</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2011.07.001</pub-id>
<pub-id pub-id-type="pmid">21943779</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capowski</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Esnault</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Malter</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA</article-title>
<source/>J Immunol
          <year>2001</year>
<volume>167</volume>
<issue>10</issue>
<fpage>5970</fpage>
<lpage>5976</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.167.10.5970</pub-id>
<pub-id pub-id-type="pmid">11698476</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esnault</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Malter</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Hyaluronic acid or TNF-alpha plus fibronectin triggers granulocyte macrophage-colony-stimulating factor mRNA stabilization in eosinophils yet engages differential intracellular pathways and mRNA binding proteins</article-title>
<source/>J Immunol
          <year>2003</year>
<volume>171</volume>
<issue>12</issue>
<fpage>6780</fpage>
<lpage>6787</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.171.12.6780</pub-id>
<pub-id pub-id-type="pmid">14662883</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tomigahara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shiraki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mikami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<issue>6</issue>
<fpage>4485</fpage>
<lpage>4492</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.151936</pub-id>
<pub-id pub-id-type="pmid">21115500</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hozumi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sumiyoshi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mine</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Anti-fibrotic effects of a novel small compound on the regulation of cytokine production in a mouse model of colorectal fibrosis</article-title>
<source/>Biochem Biophys Res Commun
          <year>2015</year>
<volume>468</volume>
<issue>4</issue>
<fpage>554</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2015.10.123</pub-id>
<pub-id pub-id-type="pmid">26603932</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Adhami</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Lall</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Sechi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Haidar</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Mukhtar</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin</article-title>
<source/>Oncotarget
          <year>2014</year>
<volume>5</volume>
<issue>9</issue>
<fpage>2462</fpage>
<lpage>2474</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.1790</pub-id>
<pub-id pub-id-type="pmid">24770864</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunasekaran</surname>
<given-names>Vinoth Prasanna</given-names>
</name>
<name>
<surname>Nishi</surname>
<given-names>Kumari</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>Dakshinamurthy</given-names>
</name>
<name>
<surname>Sivaraman</surname>
<given-names>Thirunavukkarasu</given-names>
</name>
<name>
<surname>Mathan</surname>
<given-names>Ganeshan</given-names>
</name>
</person-group>
<article-title>Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer</article-title>
<source/>European Journal of Pharmaceutical Sciences
          <year>2018</year>
<volume>116</volume>
<fpage>2</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejps.2017.09.019</pub-id>
<pub-id pub-id-type="pmid">28916481</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tafuri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Troiano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cimmino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fioretto</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Guarino</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pollice</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vivo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Evidente</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carotenuto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Calabro</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Anti-proliferative and pro-apoptotic effects of Uncaria tomentosa aqueous extract in squamous carcinoma cells</article-title>
<source/>J Ethnopharmacol
          <year>2018</year>
<volume>211</volume>
<fpage>285</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2017.09.031</pub-id>
<pub-id pub-id-type="pmid">28964869</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mundade</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hartley</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McElyea</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Temm</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Sandusky</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-kappaB in colon cancer</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<issue>30</issue>
<fpage>29396</fpage>
<lpage>29412</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.5120</pub-id>
<pub-id pub-id-type="pmid">26318844</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<mixed-citation publication-type="other">Martin M, Hua L, Wang B, Wei H, Prabhu L, Hartley AV, Jiang G, Liu Y, Lu T. Novel serine 176 phosphorylation of YBX1 activates NF-kappaB in colon cancer. J Biol Chem. 2017;292(8):3433–444.</mixed-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Frazier</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Transcription factors that interact with p53 and Mdm2</article-title>
<source/>Int J Cancer
          <year>2016</year>
<volume>138</volume>
<issue>7</issue>
<fpage>1577</fpage>
<lpage>1585</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.29663</pub-id>
<pub-id pub-id-type="pmid">26132471</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Homer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Hananeia</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sheard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Risk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lasham</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Royds</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Braithwaite</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Y-box factor YB1 controls p53 apoptotic function</article-title>
<source/>Oncogene
          <year>2005</year>
<volume>24</volume>
<issue>56</issue>
<fpage>8314</fpage>
<lpage>8325</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1208998</pub-id>
<pub-id pub-id-type="pmid">16158057</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ise</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uchiumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kuwano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kohno</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression</article-title>
<source/>Oncogene
          <year>2000</year>
<volume>19</volume>
<issue>54</issue>
<fpage>6194</fpage>
<lpage>6202</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1204029</pub-id>
<pub-id pub-id-type="pmid">11175333</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Putta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lanting</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Todorov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<issue>44</issue>
<fpage>34004</fpage>
<lpage>34015</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.165027</pub-id>
<pub-id pub-id-type="pmid">20713358</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dooley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Said</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Gressner</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects</article-title>
<source/>J Biol Chem
          <year>2006</year>
<volume>281</volume>
<issue>3</issue>
<fpage>1784</fpage>
<lpage>1795</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M510215200</pub-id>
<pub-id pub-id-type="pmid">16278212</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lenardo</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>30 years of NF-kappaB: a blossoming of relevance to human pathobiology</article-title>
<source/>Cell
          <year>2017</year>
<volume>168</volume>
<issue>1–2</issue>
<fpage>37</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.12.012</pub-id>
<pub-id pub-id-type="pmid">28086098</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Behar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Lessons from mathematically modeling the NF-kappaB pathway</article-title>
<source/>Immunol Rev
          <year>2012</year>
<volume>246</volume>
<issue>1</issue>
<fpage>221</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01092.x</pub-id>
<pub-id pub-id-type="pmid">22435558</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayden</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Regulation of NF-kappaB by TNF family cytokines</article-title>
<source/>Semin Immunol
          <year>2014</year>
<volume>26</volume>
<issue>3</issue>
<fpage>253</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1016/j.smim.2014.05.004</pub-id>
<pub-id pub-id-type="pmid">24958609</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maubach</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schmadicke</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>NEMO links nuclear factor-kappaB to human diseases</article-title>
<source/>Trends Mol Med
          <year>2017</year>
<volume>23</volume>
<issue>12</issue>
<fpage>1138</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2017.10.004</pub-id>
<pub-id pub-id-type="pmid">29128367</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbas</surname>
<given-names>Abul K.</given-names>
</name>
<name>
<surname>Trotta</surname>
<given-names>Eleonora</given-names>
</name>
<name>
<surname>R. Simeonov</surname>
<given-names>Dimitre</given-names>
</name>
<name>
<surname>Marson</surname>
<given-names>Alexander</given-names>
</name>
<name>
<surname>Bluestone</surname>
<given-names>Jeffrey A.</given-names>
</name>
</person-group>
<article-title>Revisiting IL-2: Biology and therapeutic prospects</article-title>
<source/>Science Immunology
          <year>2018</year>
<volume>3</volume>
<issue>25</issue>
<fpage>eaat1482</fpage>
<pub-id pub-id-type="doi">10.1126/sciimmunol.aat1482</pub-id>
<pub-id pub-id-type="pmid">29980618</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malek</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Matsutani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Adeegbe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>IL-2 family of cytokines in T regulatory cell development and homeostasis</article-title>
<source/>J Clin Immunol
          <year>2008</year>
<volume>28</volume>
<issue>6</issue>
<fpage>635</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1007/s10875-008-9235-y</pub-id>
<pub-id pub-id-type="pmid">18726679</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyman</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sprent</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The role of interleukin-2 during homeostasis and activation of the immune system</article-title>
<source/>Nat Rev Immunol
          <year>2012</year>
<volume>12</volume>
<issue>3</issue>
<fpage>180</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1038/nri3156</pub-id>
<pub-id pub-id-type="pmid">22343569</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malek</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>The biology of interleukin-2</article-title>
<source/>Annu Rev Immunol
          <year>2008</year>
<volume>26</volume>
<fpage>453</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090357</pub-id>
<pub-id pub-id-type="pmid">18062768</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braithwaite</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Del Sal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Some p53-binding proteins that can function as arbiters of life and death</article-title>
<source/>Cell Death Differ
          <year>2006</year>
<volume>13</volume>
<issue>6</issue>
<fpage>984</fpage>
<lpage>993</lpage>
<pub-id pub-id-type="doi">10.1038/sj.cdd.4401924</pub-id>
<pub-id pub-id-type="pmid">16575404</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meek</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Regulation of the p53 response and its relationship to cancer</article-title>
<source/>Biochem J
          <year>2015</year>
<volume>469</volume>
<issue>3</issue>
<fpage>325</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20150517</pub-id>
<pub-id pub-id-type="pmid">26205489</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogelstein</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Surfing the p53 network</article-title>
<source/>Nature
          <year>2000</year>
<volume>408</volume>
<issue>6810</issue>
<fpage>307</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1038/35042675</pub-id>
<pub-id pub-id-type="pmid">11099028</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aloni-Grinstein</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Molchadsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rotter</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>p53 on the crossroad between regeneration and cancer</article-title>
<source/>Cell Death Differ
          <year>2017</year>
<volume>24</volume>
<issue>1</issue>
<fpage>8</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1038/cdd.2016.117</pub-id>
<pub-id pub-id-type="pmid">27768121</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffy</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Synnott</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>McGowan</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Crown</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O'Connor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>p53 as a target for the treatment of cancer</article-title>
<source/>Cancer Treat Rev
          <year>2014</year>
<volume>40</volume>
<issue>10</issue>
<fpage>1153</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="doi">10.1016/j.ctrv.2014.10.004</pub-id>
<pub-id pub-id-type="pmid">25455730</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loeffler</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Transforming growth factor-beta and the progression of renal disease</article-title>
<source/>Nephrol Dial Transplant
          <year>2014</year>
<volume>29</volume>
<issue>Suppl 1</issue>
<fpage>i37</fpage>
<lpage>i45</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gft267</pub-id>
<pub-id pub-id-type="pmid">24030832</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yingling</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Sawyer</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Development of TGF-beta signalling inhibitors for cancer therapy</article-title>
<source/>Nat Rev Drug Discov
          <year>2004</year>
<volume>3</volume>
<issue>12</issue>
<fpage>1011</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1038/nrd1580</pub-id>
<pub-id pub-id-type="pmid">15573100</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gewin</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Imatinib: novel treatment of immune-mediated kidney injury</article-title>
<source/>J Am Soc Nephrol
          <year>2013</year>
<volume>24</volume>
<issue>5</issue>
<fpage>694</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2012080818</pub-id>
<pub-id pub-id-type="pmid">23431076</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spiera</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Imatinib and the treatment of fibrosis: recent trials and tribulations</article-title>
<source/>Curr Rheumatol Rep
          <year>2011</year>
<volume>13</volume>
<issue>1</issue>
<fpage>51</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1007/s11926-010-0146-6</pub-id>
<pub-id pub-id-type="pmid">21086081</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>A remedy for kidney disease successfully alters the cold shock protein response during inflammation</article-title>
<source/>Kidney Int
          <year>2016</year>
<volume>90</volume>
<issue>6</issue>
<fpage>1148</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1016/j.kint.2016.07.041</pub-id>
<pub-id pub-id-type="pmid">27884304</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tomigahara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shirasaki</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takehara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis</article-title>
<source/>Arthritis Rheum
          <year>2009</year>
<volume>60</volume>
<issue>11</issue>
<fpage>3465</fpage>
<lpage>3475</lpage>
<pub-id pub-id-type="doi">10.1002/art.24934</pub-id>
<pub-id pub-id-type="pmid">19877032</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inagaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kushida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Higashiyama</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Kawada</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Namikawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kiyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bou-Gharios</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okazaki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice</article-title>
<source/>Gastroenterology
          <year>2005</year>
<volume>129</volume>
<issue>1</issue>
<fpage>259</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2005.03.088</pub-id>
<pub-id pub-id-type="pmid">16012952</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fujimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakatsuka</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<issue>44</issue>
<fpage>43470</fpage>
<lpage>43479</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M302339200</pub-id>
<pub-id pub-id-type="pmid">12917425</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norman</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Shakib</surname>
<given-names>K</given-names>
</name>
<name>
<surname>En-Nia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<issue>32</issue>
<fpage>29880</fpage>
<lpage>29890</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M103145200</pub-id>
<pub-id pub-id-type="pmid">11395503</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syed</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Adhami</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Mukhtar</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin</article-title>
<source/>Anti Cancer Agents Med Chem
          <year>2013</year>
<volume>13</volume>
<issue>7</issue>
<fpage>995</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.2174/18715206113139990129</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Tyagi</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Deshmukh-Taskar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hinojosa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols</article-title>
<source/>Arch Biochem Biophys
          <year>2014</year>
<volume>559</volume>
<fpage>91</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.abb.2014.06.006</pub-id>
<pub-id pub-id-type="pmid">24946050</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adhami</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mukhtar</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management</article-title>
<source/>Biochem Pharmacol
          <year>2012</year>
<volume>84</volume>
<issue>10</issue>
<fpage>1277</fpage>
<lpage>1281</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2012.07.012</pub-id>
<pub-id pub-id-type="pmid">22842629</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syed</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Chamcheu</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Sechi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lall</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Adhami</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Mukhtar</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling</article-title>
<source/>Biochem Pharmacol
          <year>2014</year>
<volume>89</volume>
<issue>3</issue>
<fpage>349</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2014.03.007</pub-id>
<pub-id pub-id-type="pmid">24675012</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutherland</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Kucab</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cheang</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Yorida</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Turbin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dedhar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pollak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leighton Grimes</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Badve</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huntsman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Blake-Gilks</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells</article-title>
<source/>Oncogene
          <year>2005</year>
<volume>24</volume>
<issue>26</issue>
<fpage>4281</fpage>
<lpage>4292</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1208590</pub-id>
<pub-id pub-id-type="pmid">15806160</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gieseler-Halbach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meltendorf</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pierau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weinert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heidel</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Handschuh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Braun-Dullaeus</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Schrappe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Brunner-Weinzierl</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>RSK-mediated nuclear accumulation of the cold-shock Y-box protein-1 controls proliferation of T cells and T-ALL blasts</article-title>
<source/>Cell Death Differ
          <year>2017</year>
<volume>24</volume>
<issue>2</issue>
<fpage>371</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="doi">10.1038/cdd.2016.141</pub-id>
<pub-id pub-id-type="pmid">28009354</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>21789</fpage>
<pub-id pub-id-type="doi">10.1038/srep21789</pub-id>
<pub-id pub-id-type="pmid">26899994</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalliolias</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Ivashkiv</surname>
<given-names>LB</given-names>
</name>
</person-group>
<article-title>TNF biology, pathogenic mechanisms and emerging therapeutic strategies</article-title>
<source/>Nat Rev Rheumatol
          <year>2016</year>
<volume>12</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1038/nrrheum.2015.169</pub-id>
<pub-id pub-id-type="pmid">26656660</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sollazzo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Forte</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Polverelli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perricone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ottaviani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Luatti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vianelli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cavo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Palandri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Catani</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Crucial factors of the inflammatory microenvironment (IL-1beta/TNF-alpha/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<issue>28</issue>
<fpage>43974</fpage>
<lpage>43988</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.9949</pub-id>
<pub-id pub-id-type="pmid">27304059</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vasic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hardt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heidler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haussler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wittig</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Tegeder</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Progranulin promotes peripheral nerve regeneration and reinnervation: role of notch signaling</article-title>
<source/>Mol Neurodegener
          <year>2016</year>
<volume>11</volume>
<issue>1</issue>
<fpage>69</fpage>
<pub-id pub-id-type="doi">10.1186/s13024-016-0132-1</pub-id>
<pub-id pub-id-type="pmid">27770818</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musso</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cassader</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cohney</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pinach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saba</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gambino</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Emerging liver-kidney interactions in nonalcoholic fatty liver disease</article-title>
<source/>Trends Mol Med
          <year>2015</year>
<volume>21</volume>
<issue>10</issue>
<fpage>645</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2015.08.005</pub-id>
<pub-id pub-id-type="pmid">26432021</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>XF</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>XM</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Macrophage phenotype in liver injury and repair</article-title>
<source/>Scand J Immunol
          <year>2017</year>
<volume>85</volume>
<issue>3</issue>
<fpage>166</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1111/sji.12468</pub-id>
<pub-id pub-id-type="pmid">27491503</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Hepatocytes: a key cell type for innate immunity</article-title>
<source/>Cell Mol Immunol
          <year>2016</year>
<volume>13</volume>
<issue>3</issue>
<fpage>301</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1038/cmi.2015.97</pub-id>
<pub-id pub-id-type="pmid">26685902</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Regulation of endogenous brakes to kidney fibrosis: turning the view upside down</article-title>
<source/>J Mol Med (Berl)
          <year>2017</year>
<volume>95</volume>
<issue>6</issue>
<fpage>571</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1007/s00109-017-1540-6</pub-id>
<pub-id pub-id-type="pmid">28516239</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quek</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>AF</given-names>
</name>
</person-group>
<article-title>The role of extracellular vesicles in neurodegenerative diseases</article-title>
<source/>Biochem Biophys Res Commun
          <year>2017</year>
<volume>483</volume>
<issue>4</issue>
<fpage>1178</fpage>
<lpage>1186</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.09.090</pub-id>
<pub-id pub-id-type="pmid">27659705</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howitt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>AF</given-names>
</name>
</person-group>
<article-title>Exosomes in the pathology of neurodegenerative diseases</article-title>
<source/>J Biol Chem
          <year>2016</year>
<volume>291</volume>
<issue>52</issue>
<fpage>26589</fpage>
<lpage>26597</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.R116.757955</pub-id>
<pub-id pub-id-type="pmid">27852825</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<label>192.</label>
<mixed-citation publication-type="other">Vilette D, Courte J, Peyrin JM, Coudert L, Schaeffer L, Andreoletti O, Leblanc P. Cellular mechanisms responsible for cell-to-cell spreading of prions. Cell Mol Life Sci. 2018;75(14):2575.</mixed-citation>
</ref>
<ref id="CR193">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Nobre</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>WH</given-names>
</name>
</person-group>
<article-title>GW/P-bodies and autoimmune disease</article-title>
<source/>Adv Exp Med Biol
          <year>2013</year>
<volume>768</volume>
<fpage>61</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4614-5107-5_5</pub-id>
<pub-id pub-id-type="pmid">23224965</pub-id>
</element-citation>
</ref>
<ref id="CR194">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Probing the mRNA processing body using protein macroarrays and “autoantigenomics”</article-title>
<source/>RNA
          <year>2007</year>
<volume>13</volume>
<issue>5</issue>
<fpage>704</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1261/rna.411907</pub-id>
<pub-id pub-id-type="pmid">17339575</pub-id>
</element-citation>
</ref>
<ref id="CR195">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeoung</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Bong Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Wook Song</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Autoantibody to DNA binding protein B as a novel serologic marker in systemic sclerosis</article-title>
<source/>Biochem Biophys Res Commun
          <year>2002</year>
<volume>299</volume>
<issue>4</issue>
<fpage>549</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-291X(02)02685-2</pub-id>
<pub-id pub-id-type="pmid">12459173</pub-id>
</element-citation>
</ref>
<ref id="CR196">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Krakowiak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Duncanson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boyce</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pessah</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Autism-specific maternal autoantibodies recognize critical proteins in developing brain</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e277</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.50</pub-id>
<pub-id pub-id-type="pmid">23838888</pub-id>
</element-citation>
</ref>
<ref id="CR197">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chernov</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Curmi</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mechulam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Pastre</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Atomic force microscopy reveals binding of mRNA to microtubules mediated by two major mRNP proteins YB-1 and PABP</article-title>
<source/>FEBS Lett
          <year>2008</year>
<volume>582</volume>
<issue>19</issue>
<fpage>2875</fpage>
<lpage>2881</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2008.07.019</pub-id>
<pub-id pub-id-type="pmid">18652827</pub-id>
</element-citation>
</ref>
<ref id="CR198">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornbeck</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kornhauser</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Latham</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Skrzypek</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>PhosphoSitePlus, 2014: mutations, PTMs and recalibrations</article-title>
<source/>Nucleic Acids Res
          <year>2015</year>
<volume>43</volume>
<issue>Database issue</issue>
<fpage>D512</fpage>
<lpage>D520</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gku1267</pub-id>
<pub-id pub-id-type="pmid">25514926</pub-id>
</element-citation>
</ref>
<ref id="CR199">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma</article-title>
<source/>Exp Cell Res
          <year>2016</year>
<volume>349</volume>
<issue>2</issue>
<fpage>230</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2016.10.011</pub-id>
<pub-id pub-id-type="pmid">27751836</pub-id>
</element-citation>
</ref>
<ref id="CR200">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Protein O-GlcNAcylation: emerging mechanisms and functions</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2017</year>
<volume>18</volume>
<issue>7</issue>
<fpage>452</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1038/nrm.2017.22</pub-id>
<pub-id pub-id-type="pmid">28488703</pub-id>
</element-citation>
</ref>
<ref id="CR201">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress</article-title>
<source/>J Hepatol
          <year>2017</year>
<volume>67</volume>
<issue>2</issue>
<fpage>310</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.jhep.2017.03.017</pub-id>
<pub-id pub-id-type="pmid">28347804</pub-id>
</element-citation>
</ref>
<ref id="CR202">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allison</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Wamsley</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-kappaB acetylation and transcription</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2012</year>
<volume>109</volume>
<issue>42</issue>
<fpage>16888</fpage>
<lpage>16893</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1208468109</pub-id>
<pub-id pub-id-type="pmid">23027940</pub-id>
</element-citation>
</ref>
<ref id="CR203">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhardt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fehr</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jerchel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ballhause</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Philipsen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stolze</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Geffers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Isermann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brunner-Weinzierl</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Batra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Siegmund</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inflammatory cell infiltration and resolution of kidney inflammation is orchestrated by the cold-shock protein Y-box binding protein-1</article-title>
<source/>Kidney Int
          <year>2017</year>
<volume>92</volume>
<issue>5</issue>
<fpage>1157</fpage>
<lpage>1177</lpage>
<pub-id pub-id-type="doi">10.1016/j.kint.2017.03.035</pub-id>
<pub-id pub-id-type="pmid">28610763</pub-id>
</element-citation>
</ref>
<ref id="CR204">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seko</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kasprzak</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Ragheb</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The role of cytokine mRNA stability in the pathogenesis of autoimmune disease</article-title>
<source/>Autoimmun Rev
          <year>2006</year>
<volume>5</volume>
<issue>5</issue>
<fpage>299</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2005.10.013</pub-id>
<pub-id pub-id-type="pmid">16782553</pub-id>
</element-citation>
</ref>
<ref id="CR205">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coles</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Occhiodoro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vadas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Cold shock domain proteins repress transcription from the GM-CSF promoter</article-title>
<source/>Nucleic Acids Res
          <year>1996</year>
<volume>24</volume>
<issue>12</issue>
<fpage>2311</fpage>
<lpage>2317</lpage>
<pub-id pub-id-type="doi">10.1093/nar/24.12.2311</pub-id>
<pub-id pub-id-type="pmid">8710501</pub-id>
</element-citation>
</ref>
<ref id="CR206">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertens</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Rauen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Strauch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pabst</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Rat Mrp2 gene expression is regulated by an interleukin-1beta-stimulated biphasic response with enhanced transcription and subcellular shuttling of YB-1</article-title>
<source/>Eur J Cell Biol
          <year>2012</year>
<volume>91</volume>
<issue>6–7</issue>
<fpage>533</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2011.12.002</pub-id>
<pub-id pub-id-type="pmid">22361279</pub-id>
</element-citation>
</ref>
<ref id="CR207">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silveira</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Krampe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ruhland</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Diedrich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hornung</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Agic</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cold-shock domain family member YB-1 expression in endometrium and endometriosis</article-title>
<source/>Hum Reprod
          <year>2012</year>
<volume>27</volume>
<issue>1</issue>
<fpage>173</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/der368</pub-id>
<pub-id pub-id-type="pmid">22095791</pub-id>
</element-citation>
</ref>
<ref id="CR208">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornung</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bentzien</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wallwiener</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kiesel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RN</given-names>
</name>
</person-group>
<article-title>Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid</article-title>
<source/>Mol Hum Reprod
          <year>2001</year>
<volume>7</volume>
<issue>2</issue>
<fpage>163</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1093/molehr/7.2.163</pub-id>
<pub-id pub-id-type="pmid">11160842</pub-id>
</element-citation>
</ref>
<ref id="CR209">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkins</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Bennagi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Redman</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>A conserved stem loop motif in the 5’untranslated region regulates transforming growth factor-beta(1) translation</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<issue>8</issue>
<fpage>e12283</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0012283</pub-id>
<pub-id pub-id-type="pmid">20865036</pub-id>
</element-citation>
</ref>
<ref id="CR210">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coles</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Lambrusco</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Burrows</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bert</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Vadas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Goodall</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter</article-title>
<source/>FEBS Lett
          <year>2005</year>
<volume>579</volume>
<issue>24</issue>
<fpage>5372</fpage>
<lpage>5378</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2005.08.075</pub-id>
<pub-id pub-id-type="pmid">16198352</pub-id>
</element-citation>
</ref>
<ref id="CR211">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kajino</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Umeda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arakawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kudo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hino</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis</article-title>
<source/>Int J Oncol
          <year>2002</year>
<volume>21</volume>
<issue>4</issue>
<fpage>847</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="pmid">12239625</pub-id>
</element-citation>
</ref>
<ref id="CR212">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kajino</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tobita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Uchiumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Obulhasim</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Arii</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hino</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>The up-regulation of Y-box binding proteins (DNA binding protein a and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma</article-title>
<source/>Clin Cancer Res
          <year>2005</year>
<volume>11</volume>
<issue>20</issue>
<fpage>7354</fpage>
<lpage>7361</lpage>
<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-1027</pub-id>
<pub-id pub-id-type="pmid">16243807</pub-id>
</element-citation>
</ref>
<ref id="CR213">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Obulhasim</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kajino</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mogushi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mizushima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hino</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Arii</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>DNA binding protein a expression and methylation status in hepatocellular carcinoma and the adjacent tissue</article-title>
<source/>Int J Oncol
          <year>2012</year>
<volume>40</volume>
<issue>3</issue>
<fpage>789</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="pmid">22159460</pub-id>
</element-citation>
</ref>
<ref id="CR214">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obulhasim</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yasen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kajino</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mogushi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mizushima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Arii</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hino</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome</article-title>
<source/>Hepatol Int
          <year>2013</year>
<volume>7</volume>
<issue>1</issue>
<fpage>215</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1007/s12072-012-9357-4</pub-id>
<pub-id pub-id-type="pmid">26201636</pub-id>
</element-citation>
</ref>
<ref id="CR215">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Letunic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>20 years of the SMART protein domain annotation resource</article-title>
<source/>Nucleic Acids Res
          <year>2018</year>
<volume>46</volume>
<issue>D1</issue>
<fpage>D493</fpage>
<lpage>D496</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx922</pub-id>
<pub-id pub-id-type="pmid">29040681</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>